MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Pharmacy

HealthDay 20 November at 11.06 AM

Four Million Americans Could Lose Health Coverage Once ACA Credits Expire

If Congress lets health care tax credits established during the pandemic expire, 4 million Americans will become uninsured, a new analysis warns.The tax credits, which have significantly lowered out-of-pocket costs for millions of Americans, are set to expire at the end of 2025."Allowing these credits to expire will force families to c

HealthDay 19 November at 11.50 PM

President-Elect Trump to Pick Mehmet Oz to Head CMS

President-elect Donald Trump says he will nominate Mehmet Oz, M.D., to head the Centers for Medicare & Medicaid Services.In a statement, Trump said that Oz will "work closely with Robert Kennedy Jr. to take on the illness industrial complex, and all the horrible chronic diseases left in its wake," The New York Times reported. Trump

HealthDay 19 November at 11.47 PM

Antiviral Treatment Underutilized for Children, Teens With Flu

Antiviral treatment is underutilized among children and adolescents hospitalized with influenza, according to research published in the Nov. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Using data from two U.S. influenza surveillance networks, Aaron M. Frutos, Ph.D., from the CDC

HealthDay 19 November at 04.34 PM

Risk for Emergently Treated Hypocalcemia With Denosumab Rises With CKD Stage

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with worsening CKD stage, according to a study published online Nov. 19 in the Annals of Internal Medicine.Steven T. Bird, Ph.D., Pharm.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and coll

HealthDay 19 November at 04.28 PM

ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease

For patients with immunoglobulin G (IgG)4-related disease, inebilizumab reduces the risk for flares and increases the likelihood of flare-free complete remission, according to a study published online Nov. 14 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Rheumatology, held from Nov. 14 t

HealthDay 19 November at 04.22 PM

ACR: Colchicine No Benefit for Painful Knee Osteoarthritis

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 14 to 19 in Washington, D.C.Jonathan Samuels, M.D., from NYU Langone in Rye Brook, New York, and colleagues assessed wh

HealthDay 19 November at 03.53 PM

Barriers to Widespread Access to Cancer Medications Include Excessive Cost

Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review published online Nov. 18 in Cancer.Arafat H. Tfayli, M.D., from the American University of Beirut Medical Center, and colleagues conducted a systematic review to examine the current state of cancer drug development

HealthDay 19 November at 01.29 PM

Judge Declares Wyoming's Abortion Bans Unconstitutional

Two Wyoming abortion bans, including the first state law to prohibit the use of abortion pills, violate the state's constitution, a judge ruled Monday.In her decision, Judge Melissa Owens, of Teton County District Court, wrote that both a <a href="https://wyoleg.gov/Legislation/2023/SF0109"

HealthDay 18 November at 10.56 PM

Global Coverage With Measles Vaccine Declined During COVID-19

Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023, according to research published in the Nov. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Anna A. Minta, M.D., from the Worl

HealthDay 18 November at 10.38 PM

Metformin Use Tied to Lower Rate of Asthma Attacks

Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published online Nov. 18 in&nbsp;JAMA Internal Medicine.Bohee Lee, Ph.D., from Imperial College London, and colleagues estimated the association of metformin and add-on antidiabetic medications (glucagon-like peptide-1 receptor a

HealthDay 18 November at 10.35 PM

Gabapentinoid Use Tied to Higher Risk for Hip Fractures

Gabapentinoid use is associated with an increased risk for hip fractures, according to a study published online Nov. 13 in&nbsp;JAMA Network Open.Miriam T.Y. Leung, from the Centre for Medicine Use and Safety at Monash University in Melbourne, Australia, and colleagues investigated the association between gabapentinoids and the risk for

HealthDay 18 November at 04.48 PM

Oral Infigratinib Seems Safe for Children With Achondroplasia

For children with achondroplasia, oral infigratinib does not result in major safety signals and yields increased annualized height velocity and z score at a dose of 125 mg, according to a study published online Nov. 18 in the New England Journal of Medicine.Ravi Savarirayan, M.B., B.S., M.D., from Murdoch Children's Research Institute i

HealthDay 18 November at 04.34 PM

Beta Blockers May Cause Depressive Symptoms

Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction with preserved left ventricular ejection fraction (LVEF), according to a study published online Oct. 3 in the European Heart Journal: Acute CardioVascular Care.Philip Leissner, from Uppsala University in Sweden, and

HealthDay 18 November at 04.28 PM

ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal Cancer

For patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) followed by immunochemotherapy (iCT) and then surgery is promising, according to a study published online Nov. 15 in Clinical Cancer Research.Xin Wang, from the Chinese Academy of Medical Sciences and Peking Union Medical C

HealthDay 18 November at 04.21 PM

Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study published online Nov. 13 in the New England Journal of Medicine.Ania M. Jastreboff, M.D., Ph.D., from the Yale School of Medicine in New Haven

HealthDay 18 November at 04.17 PM

Bleeding Risk Increased With NSAID Use for VTE Patients Receiving Anticoagulants

Patients with venous thromboembolism (VTE) initiating oral anticoagulants have an increased risk for bleeding when using nonsteroidal anti-inflammatory drugs (NSAIDs), according to a study published online Nov. 17 in the European Heart Journal.Søren Riis Petersen, from Aarhus University Hospital in Denmark, and colleagues conducted a na

HealthDay 14 November at 11.50 PM

FDA Approves Cobenfy for Adults With Schizophrenia

The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.The oral medication represents the first new class of medicine in several decades and selectively targets M1&nbsp;and M4&nbsp;receptors in the bra

HealthDay 14 November at 11.47 PM

President-Elect Trump Nominates Robert F. Kennedy Jr. to Lead HHS

President-elect Donald Trump has chosen Robert F. Kennedy Jr. to head the U.S. Department of Health and Human Services.The department encompasses numerous key agencies, including the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, the National Institutes of Health, Medicaid, and Medicare.In a stat

HealthDay 13 November at 01.10 PM

Big Post-Election Surge Seen in Online Sales of Morning-After Pills

In the wake of Donald Trump's victory in the presidential election, retailers report that online sales of emergency contraceptives have soared.The spike in purchases of what is also known as the morning-after pill or Plan B suggests women worry the incoming administration might soon limit their access to emergency contraception, <a href="http

HealthDay 12 November at 09.32 PM

FDA Approves Emrosi for Rosacea in Adults

The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults.The extended-release capsules (40 mg) will be available late in the first quarter or early in the second quarter of 2025.The approval was based on positive results from two 16-week phase 3 clinical tri

HealthDay 12 November at 04.28 PM

AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial infarction (MI), and recurrent stroke, according to a study presented at the American Heart Association Scientific Sessions 2024, held from Nov. 16 to 18 in

HealthDay 12 November at 03.56 PM

SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis

For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in recurrence, according to a study published online Oct. 30 in The BMJ.Natalie McCormick, Ph.D., from Massachusetts General Hospital in Boston, and colleagues emulated target trials comparing recurrence of nephrolith

HealthDay 08 November at 04.39 PM

Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines, according to a study published online Nov. 6 in JAMA Network Open.Emmanuel B. Walter, M.D., M.P.H., from the Duke University School of Medicine in Durham, North Carolina, and colleagues compared the reactogenicity, safety,

HealthDay 07 November at 04.26 PM

FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine

More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug Administration is proposing that it be removed from common over-the-counter decongestants.Products that in

HealthDay 07 November at 04.22 PM

Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year

Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually in the United States, according to a study published online Oct. 15 in the Proceedings of the National Academy of Sciences.Abhishek Pand

HealthDay 07 November at 12.24 PM

Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least 100 hospitalizations and 10 deaths.“Honestly, I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO <a href="https://w

HealthDay 06 November at 10.17 PM

Medication Abortion Before Confirmed Intrauterine Pregnancy Noninferior

For complete abortion, medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment, according to a study published in the Nov. 7 issue of the New England Journal of Medicine.Karin Brandell, M.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a multicenter, noninferi

HealthDay 06 November at 12.48 PM

Abortion Rights Measures Pass in 7 States, Fail in 3

In election results that showed protecting women's reproductive freedoms matter to a majority of Americans, abortion rights measures passed in seven states and failed in three.Missouri, Arizona, Nevada, Colorado, New York, Maryland and Montana all backed those rights, while such amendments were defeated in Florida, Nebraska and South Dakota, l

HealthDay 05 November at 04.34 PM

Smoking Cessation Aids Survival Even Following a Cancer Diagnosis

Evidence-based smoking cessation treatment within six months of a cancer diagnosis maximizes survival benefit, according to a study published online Oct. 31 in&nbsp;JAMA Oncology.Paul M. Cinciripini, Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined the association between time of entry in

HealthDay 05 November at 04.29 PM

Guidance Issued for Safe Use of GLP-1 RAs in the Perioperative Period

In a multisociety clinical practice guidance document, published online Oct. 29 in Surgery for Obesity and Related Diseases, recommendations are presented for the safe use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the perioperative period.Noting that GLP-1 RAs have revolutionized the care of patients with metabolic dis

HealthDay 05 November at 04.19 PM

Recreational Cannabis Legalization Tied to Higher Prenatal Use

The implementation of recreational cannabis legalization (RCL) in California was associated with an increase in prenatal cannabis use, according to a study published online Nov. 1 in&nbsp;JAMA Health Forum.Kelly C. Young-Wolff, Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues assessed whether RCL in Califo

HealthDay 05 November at 11.04 AM

Medicaid Covers GLP-1 Meds for Obesity in Just 13 States

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered.Under the Medicaid system, individual states are allowed to deci

HealthDay 04 November at 04.32 PM

Multiple Penicillin Courses Linked to Modestly Lower Risk for Parkinson Disease

Adults who have received multiple penicillin courses have a modestly lower risk for Parkinson disease (PD), according to a study published in the October issue of Parkinsonism and Related Disorders.Gian Pal, M.D., from the Rutgers-Robert Wood Johnson Medical School in New Brunswick, New Jersey, and colleagues conducted a nested case-cont

HealthDay 04 November at 01.01 PM

In a National First, an Idaho Health Department Is Refusing to Give COVID Vaccines

In what may be a first for the United States, a regional public health department in Idaho will no longer provide COVID-19 vaccines, following a close vote by its board.“I’m not aware of anything else like this,” said Adriane Casalotti, chief of government and public affairs for the Nati

HealthDay 01 November at 10.57 PM

Supply Chain Issues Less Likely to Yield Drug Shortages in Canada Versus U.S.

Drug-related reports of supply chain issues are less likely to result in drug shortages in Canada than in the United States, according to a study published online Oct. 31 in the Journal of the American Medical Association.Mina Tadrous, Pharm.D., Ph.D., from the University of Toronto, and colleagues compared how frequently reports of drug

HealthDay 01 November at 04.24 PM

Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered

Countries with COVID-19 pandemic-associated reductions in childhood immunization coverage have not yet recovered, according to research published in the Oct. 31 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Camille E. Jones, Ph.D., from the CDC in Atlanta, and colleagues present trends

HealthDay 01 November at 04.22 PM

Flu Vaccine Coverage 80.7 Percent for Health Workers in Acute Care Hospitals

Influenza and 2023 to 2024 COVID-19 vaccination coverage is 80.7 and 15.3 percent, respectively, among health care personnel at acute care hospitals and is lower among health care personnel at nursing homes, according to research published in the Oct. 31 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Repo

HealthDay 01 November at 03.46 PM

Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DM

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications, according to a study published online Oct. 24 in Alzheimer's &amp; Dementia.William Wang, from the Case Western Reserve University School of Medicine in

HealthDay 01 November at 03.41 PM

ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 25 to 30 in Philadelphia.Temitope Olasehinde, M.D., from

HealthDay 31 October at 03.38 PM

Semaglutide Beneficial for People With Obesity, Knee Osteoarthritis

For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and pain related to knee osteoarthritis than placebo, according to a study published in the Oct. 31 issue of the New England Journal of Medicine.Henning Bliddal, M.D., from the Copenhagen University Hospital at Bispeb

HealthDay 31 October at 03.35 PM

Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer

Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer, according to a study published in the Oct. 3

HealthDay 31 October at 03.22 PM

Micronized Amnion/Chorion Aids Interstitial Cystitis/Bladder Pain Syndrome

Injected micronized amnion/chorion bilayer (AC) product significantly reduces time to symptom relief in patients with refractory interstitial cystitis/bladder pain syndrome (IC/BPS), according to a study published online Oct. 23 in&nbsp;International Urology &amp; Nephrology.Kyle O’Hollaren, from Wayne State University School of Medic

HealthDay 31 October at 03.05 PM

ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome

Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 25 to 30 in Philadelphia.Jacqueline Khalil, D.O., from Case Western Reserve University in

HealthDay 30 October at 10.12 PM

Generic Medications Can Keep OOP Costs Down for Neurological Conditions

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a study published online Oct. 30 in Neurology.Amanda V. Gusovsky, Ph.D., M.P.H., from the Wexner Medical Center at The Ohio State University in Columbus, and co

HealthDay 30 October at 03.37 PM

Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer

For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, according to a study published online Oct. 23 in The BMJ.Min He, from Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer, and colleagues conducted a randomized phase 3 trial in seven cancer centers

HealthDay 30 October at 03.33 PM

Small but Important Differences Seen Between Rosuvastatin, Atorvastatin

There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29 in&nbsp;Annals of Internal Medicine.Shiyu Zhou, M.D., from Southern Medical University in Guangzhou, China, and colleagues compared the real-world effectiveness and

HealthDay 30 October at 03.31 PM

ASN: Atrasentan Significantly and Clinically Meaningfully Cuts Proteinuria

Atrasentan is associated with a significant and clinically meaningful reduction in proteinuria compared with placebo in patients with immunoglobulin A (IgA) nephropathy, according to a study published online Oct. 25 in the New England Journal of Medicine to coincide with Kidney Week, the annual meeting of the American Society of Nephrology,

HealthDay 29 October at 03.50 PM

Urine Drug Test Concentrations Up for Fentanyl, Methamphetamine, Cocaine

Absolute concentrations of fentanyl, methamphetamine, and cocaine in urine specimens increased from 2013 to 2023, according to a study published online Oct. 24 in&nbsp;JAMA Network Open.Andrew S. Huhn, Ph.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues analyzed urine drug testing (UDT) results to q

HealthDay 29 October at 03.48 PM

Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries

Among privately insured patients, there was a doubling in the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as antiobesity treatment from 2022 to 2023, with a simultaneous 25.6 percent decrease in the rate of metabolic bariatric surgery, according to a research letter published online Oct. 25 in&nbsp;JAMA Network Open.Ke

HealthDay 29 October at 03.45 PM

ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma

For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined with the long-acting β agonist formoterol are each associated with reduced asthma exacerbations compared with SABA alone, according to a study published online Oct. 28 in the Journal of the American Medical Association. The st

HealthDay 29 October at 03.42 PM

Clinical Practice Guideline Updated for Migraine, Tension-Type Headache

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Annals of Internal Medicine, updated recommendations are presented for the management of migraine and tension-type headache (TTH).Noting that the 2020 U.S. Department of Veterans Af

HealthDay 28 October at 10.38 PM

Clinical Practice Guidelines Updated for Primary Prevention of Stroke

In a clinical guideline issued by the American Heart Association and American Stroke Association and published online Oct. 21 in Stroke, updated recommendations are presented for the primary prevention of stroke.Cheryl Bushnell, M.D., from Wake Forest University in Winston-Salem, North Carolina, and colleagues conducted a systematic rev

HealthDay 28 October at 04.06 PM

ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin

For patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer OHE episodes than lactulose (LAC) MT, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 25 to 30 in Philadelphia.Jasmohan S. Bajaj, M.D., from Virginia Commonw

HealthDay 28 October at 04.04 PM

ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients

Empagliflozin continues to offer cardiorenal benefits for up to 12 months after discontinuation among patients with chronic kidney disease at risk for progression, according to a study published online Oct. 25 in the New England Journal of Medicine to coincide with Kidney Week, the annual meeting of the American Society of Nephrology, held fro

HealthDay 28 October at 03.39 PM

2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 Diabetes

From 2010 to 2023, there was an increase in prescribing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium glucose cotransporter 2 (SGLT2) inhibitors among individuals with type 1 diabetes (T1D), according to a research letter published online Oct. 23 in the Journal of the American Medical Association.Piaopiao Li, from

HealthDay 25 October at 08.32 PM

Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis

Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in&nbsp;JAMA Dermatology.Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues evaluated the effi

HealthDay 25 October at 04.08 PM

ACAAI: Most Syphilis Patients With Penicillin Allergy Have Low Risk for Severe Allergy

Delabeling patients with syphilis who believe they are allergic to penicillin is safe, according to a study presented at the annual meeting of the American College of Allergy, Asthma &amp; Immunology, held from Oct. 24 to 28 in Boston.Aiwei Yan, M.D., from the Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues retrospec

HealthDay 25 October at 04.05 PM

Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue

Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue, according to a study published in the November issue of The Lancet Neurology. Tiffany J. Braley, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a randomized, comparative effectiveness

HealthDay 25 October at 04.02 PM

ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated

Many anaphylaxis protocols are incomplete and/or outdated, and there is a need for patient education regarding treatment of anaphylaxis, according to two studies presented at the annual meeting of the American College of Allergy, Asthma &amp; Immunology, held from Oct. 24 to 28 in Boston.Carly Gunderson, D.O., from the Baylor College of Medicine

HealthDay 25 October at 03.56 PM

GIP/GLP-1 RA Beneficial for Patients With Opioid, Alcohol Use Disorder

For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 RA) are associated with lower rates of opioid overdose and alcohol intoxication, according to a study published online Oct. 16 in Addiction.<

HealthDay 25 October at 11.58 AM

CDC Says Some People May Need Extra Dose of COVID Vaccine

Some Americans should get more than one shot of the updated COVID vaccines because their age or certain health conditions make them more vulnerable to severe infections, U.S. health officials advised this week.Six months after their first shot, people 65 and older and those who are immunocompromised should receive a second dose of the&nbsp;vacci

HealthDay 24 October at 03.44 PM

ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema

For adults with hereditary angioedema, the in vivo gene-editing therapy NTLA-2002, which is based on clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9, administered as a single dose reduces angioedema attacks, according to a study published online Oct. 24 in the New England Journal of Medicine to

HealthDay 24 October at 12.30 PM

CDC Lowers Age for First Pneumococcal Vaccine to 50

The recommended first age at which Americans should get the pneumococcal vaccine has been lowered from 65 to 50, the U.S. Centers for Disease Control and Prevention announced Wednesday."Lowering the age for pneumococcal vaccination gives more adults the opportunity to protect themselves from pneumococcal disease at the age when risk of infecti

HealthDay 23 October at 03.47 PM

AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus

One year of valacyclovir is beneficial for patients with herpes zoster ophthalmicus (HZO), according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.Elisabeth Cohen, M.D., from the NYU Grossman School of Medicine and NYU Langone Health in New York City, and colleagues con

HealthDay 23 October at 02.40 PM

FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer

The U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma who

HealthDay 23 October at 12.40 PM

Abortions Have Increased, Even in States With Bans, Report Finds

A new report shows the number of women getting abortions in the United States has actually increased since the U.S. Supreme Court overturned Roe v. Wade.Since March 2023, the #WeCount report found a small, consistent increase in abortion rates.

HealthDay 22 October at 10.48 PM

AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine

For patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is not uncommon, but usually resolves, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.Filippos Vingopoulos, M.D., Ph.D., from Stanford Univers

HealthDay 22 October at 10.47 PM

AAO: Wastage Seen With Artificial Expiration of Eye Drops in Ophthalmic Clinics

Artificial expiration dates on eye drops in ophthalmology clinics result in significant waste in terms of medication, plastic, and cost, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.Noting that eye drops in ophthalmology clinics have artificial expiration dates

HealthDay 22 October at 10.45 PM

FDA Approves Vyalev for Advanced Parkinson Disease

The U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson disease (PD).Vyalev is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced PD and allows for personalized dosing throughout the d

HealthDay 22 October at 03.33 PM

No Objective Improvement Seen in Cognitive Function With Exercise During Chemo

Aerobic exercise does not result in differences in objective cognitive function after chemotherapy completion among women with breast cancer, according to a study published online Oct. 21 in Cancer.Jennifer Brunet, Ph.D., from the University of Ottawa in Ontario, Canada, and colleagues examined the effects of an aerobic exercise interv

HealthDay 21 October at 10.49 PM

People With Inflammatory Bowel Disease Face Barriers to Health Care

Patients with inflammatory bowel disease (IBD) continue to experience barriers to health care access and treatment and financial struggles, according to a study published online Oct. 8 in&nbsp;Inflammatory Bowel Diseases.Ariel A. Jordan, M.D., from University of Michigan in Ann Arbor, and colleagues surveyed IBD patients and their careg

HealthDay 21 October at 03.50 PM

IDSA: Antibiotics for Seven Days Feasible for Patients Hospitalized With Bloodstream Infections

Treating hospitalized patients with bloodstream infections with antibiotics for seven days is noninferior to treating for 14 days, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in &nbsp;Los Angeles.Nick Daneman, M.D., and Rob Fowler, M.D., from the University

HealthDay 21 October at 03.38 PM

Preexposure Prophylaxis Use Increased in Recent Years

Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 in the&nbsp;Journal of the American Medical Association.Laura M. Mann, Ph.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues used the IQVIA Real-World Longitudinal Presc

HealthDay 21 October at 03.35 PM

Pembrolizumab Aids Survival With High-Risk Endometrial Cancer

Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published online Oct. 16 in the&nbsp;Journal of Clinical Oncology.Brian M. Slomovitz, M.D., from Mount Sinai Medical Center in Miami Beach, and colleagues conducted a

HealthDay 21 October at 12.45 PM

Biden Proposes That Insurers Cover Over-the-Counter Birth Control

Health insurers would be required to cover the cost of over-the-counter birth control and emergency contraception under new rules proposed by the White House on Monday."Since Roe v. Wade was overturned more than two years ago, Republican elected officials have made clear they want to ban or restrict birth control, defund federal programs that he

HealthDay 18 October at 04.07 PM

IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race

Vaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing social vulnerability index (SVI) and Black race, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Ange

HealthDay 18 October at 03.35 PM

Annual Wasteful Spending on Lecanemab Estimated at $133 to $336 Million

Annual wasteful spending on discarded lecanemab is anticipated to range between $133 and $336 million, given current vial sizes, according to a research letter published online Oct. 14 in JAMA Internal Medicine.Noting that lecanemab dosing is weight-based and only available in 500- and 200-mg vials, Frank F. Zhou, from the David Geffen

HealthDay 17 October at 09.43 PM

IDSA: MVA-BN Vaccine Against Mpox Tolerated, Effective for Teens

The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.Catherine Mary Healy

HealthDay 17 October at 09.40 PM

IDSA: EHR Order Set Reduces Antibiotic Duration in Children With AOM

Implementation of an electronic health record (EHR) order set increases compliance with the recommended duration of prescribed antibiotics for children with acute otitis media (AOM), according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.Joana Dimo, D.

HealthDay 17 October at 04.03 PM

2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS

From 2013 to 2021, there was a decline in benzodiazepine initiation for post-acute ischemic stroke (AIS), according to a study published online Oct. 17 in Stroke.Victor Lomachinsky Torres, M.D., from Massachusetts General Hospital in Boston, and colleagues analyzed a 20 percent sample of U.S. Medicare claims from April 1, 2013, to Sep

HealthDay 17 October at 03.59 PM

Tenecteplase Has Similar Safety to TPA for Acute Ischemic Stroke

For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator [TPA]), according to a study published online Oct. 16 in Neurology.Lina Palaiodimou, M.D., Ph.D., from the National and Kapodistrian University of Athens

HealthDay 17 October at 03.39 PM

Paternal Metformin Use Does Not Increase Risk for Congenital Malformations

Paternal metformin use during the period of sperm development is not associated with an increased risk for congenital malformations in offspring, according to a study published online Oct. 16 in The BMJ.Lin-Chieh Meng, from the National Taiwan University, and colleagues examined the association between paternal metformin use and the r

HealthDay 16 October at 09.55 PM

Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma

For patients with stage III or IV Hodgkin lymphoma, nivolumab with doxorubicin, vinblastine, and dacarbazine (N+AVD) yields longer progression-free survival (PFS) than brentuximab vedotin with doxorubicin, vinblastine, and dacarbazine (BV+AVD), according to a study published online Oct. 16 in the New England Journal of Medicine.Alex

HealthDay 16 October at 03.25 PM

Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a previous metformin prescription, according to a research letter published online Oct. 16 in&nbsp;JAMA Network Open.Margaret G. Miller, from Case Western Re

HealthDay 16 October at 03.19 PM

Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination

COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis after mRNA vaccination, according to a study published online Sept. 30 in the European Heart Journal.Yiyi Xu, Ph.D., from the

HealthDay 16 October at 03.06 PM

FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer

The U.S. Food and Drug Administration approved Itovebi (inavolisib), in combination with palbociclib (Ibrance) and fulvestrant, for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer.Th

HealthDay 16 October at 03.02 PM

Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF

For individuals with heart failure with reduced ejection fraction (HFrEF), substantial mortality benefits would result from optimal use of guideline-directed medical therapy (GDMT), according to a study published online Oct. 2 in JAMA Cardiology.Amber B. Tang, M.D., from the University of California Los Angeles, and colleagues examin

HealthDay 16 October at 02.51 PM

Rate of Layperson-Administered Naloxone Increased From 2020 to 2022

The rate of layperson-administered naloxone (LAN) increased from 2020 to 2022, according to a study published online Oct. 14 in&nbsp;JAMA Network Open.Christopher B. Gage, from Ohio State University in Columbus, and colleagues assessed whether the frequency of LAN in conjunction with emergency medical services (EMS) activations chang

HealthDay 15 October at 04.10 PM

Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct. 14 in JAMA Pediatrics.Liya Kerem, M.D., and Joshua Stokar, M.D., from Hadassah University Medical Center in Israel, examined the incid

HealthDay 15 October at 04.10 PM

Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct. 14 in JAMA Pediatrics.Liya Kerem, M.D., and Joshua Stokar, M.D., from Hadassah University Medical Center in Israel, examined the incid

HealthDay 15 October at 04.05 PM

American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid Shortage

The American Thoracic Society is providing tips to help hospitals mitigate impacts on intravenous (IV) fluid supply resulting from manufacturing disruptions due to recent hurricanes.W. Graham Carlos, M.D., and colleagues provide guidance on how health care systems facing shortages of these fluids may conserve fluids and address the shortages.</

HealthDay 15 October at 04.05 PM

American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid Shortage

The American Thoracic Society is providing tips to help hospitals mitigate impacts on intravenous (IV) fluid supply resulting from manufacturing disruptions due to recent hurricanes.W. Graham Carlos, M.D., and colleagues provide guidance on how health care systems facing shortages of these fluids may conserve fluids and address the shortages.</

HealthDay 15 October at 04.01 PM

FDA Approves Hympavzi for Hemophilia

The U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors.Unlike other drugs that replace a c

HealthDay 15 October at 03.49 PM

Lithium Aspartate Not Effective for Neurologic Long COVID Fatigue

Lithium aspartate is not effective for neurologic post-COVID-19 condition (PCC) symptoms of fatigue and cognitive dysfunction, according to a study published online Oct. 2 in JAMA Network Open.Thomas Guttuso Jr., M.D., from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in Williamsville, New York, an

HealthDay 15 October at 03.40 PM

15.5 Million Adults Had Current ADHD Diagnosis in 2023

An estimated 15.5 million U.S adults had a current diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2023, according to research published in the Oct. 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Brooke S. Staley, Ph.D., from the CDC in Atlanta, and colleagues estim

HealthDay 15 October at 12.32 PM

FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.What prompted the FDA to reconsider its <a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-pol

HealthDay 11 October at 09.07 PM

Letter Nudges Increase Likelihood of Flu Vaccination for Adults With Chronic Diseases

For patients aged 18 to 64 years with chronic diseases, electronically delivered letter nudges increase influenza vaccination rates compared with usual care, according to a study published online Oct. 11 in the Journal of the American Medical Association.Niklas Dyrby Johansen, M.D., Ph.D., from Copenhagen University Hospital -- Herlev a

HealthDay 11 October at 03.53 PM

Industry Payments Common for Physician Peer Reviewers of Top Journals

More than half of U.S. physician peer reviewers for the most influential medical journals receive industry payments, according to a research letter published online Oct. 10 in the&nbsp;Journal of the American Medical Association.David-Dan Nguyen, M.P.H., from the University of Toronto, and colleagues characterized payments by drug and m

HealthDay 11 October at 03.51 PM

Benzene Exposure Results From Benzoyl Peroxide Drug Product Use

Potential benzene exposure occurs as a result of benzoyl peroxide (BPO) drug product use, according to a study published online Oct. 7 in the Journal of Investigative Dermatology.The carcinogen benzene is a degradation product of BPO and has been reported to form when BPO drug products are incubated at body temperature and elevated temp

HealthDay 11 October at 03.36 PM

Lentiviral Gene Therapy Beneficial for Early Cerebral Adrenoleukodystrophy

For boys with early-stage cerebral adrenoleukodystrophy and evidence of active inflammation, lentiviral elivaldogene autotemcel (eli-cel) gene therapy offers lasting benefits, according to a study published in the Oct. 10 issue of the New England Journal of Medicine.Florian Eichler, M.D., from Massachusetts General Hospital and Harvard

HealthDay 10 October at 03.27 PM

Availability, Timeliness of Availability of New Cancer Drugs Vary

Across countries, there are considerable disparities in the availability and timeliness of availability of new cancer drugs, according to a study published online Oct. 8 in BMJ Global Health.Meng Li, Ph.D., from Tufts Medical Center in Boston, and colleagues examined the availability and timeliness of availability of new cancer drugs

HealthDay 09 October at 10.16 PM

Antidepressant Warnings Had Unintended Impact on Youth Mental Health

Youth antidepressant warnings had a detrimental unintended effect: significant reductions in mental health care, according to a report published in the October issue of Health Affairs.Noting that since 2003 the U.S. Food and Drug Administration has warned that antidepressants may be associated with suicidal thoughts and behaviors amon

HealthDay 09 October at 03.59 PM

Lamotrigine, Mexiletine Show Similar Benefits for Nondystrophic Myotonias

Improvements in nondystrophic myotonias symptoms are similar for lamotrigine and mexiletine, according to a study published in the October issue of&nbsp;The Lancet Neurology.Vinojini Vivekanandam, Ph.D., from the Centre for Neuromuscular Disorders at the National Hospital for Neurology and Neurosurgery in London, and colleagues random

HealthDay 09 October at 03.51 PM

Dronabinol Safe, Effective for Alzheimer Disease With Agitation

Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study presented at the annual meeting of the International Psychogeriatric Association, held from Sept. 25 to 27 in Buenos Aires, Argentina.Paul Rosenberg, M.D., from Johns Hopkins University School of Medicine in Baltimore, and col

HealthDay 09 October at 03.38 PM

Most Pediatric Opioid Exposures Occur in Young Child's Home

Nine in 10 pediatric opioid exposures occur unintentionally in the home, according to a brief report published online Aug. 14 in The Journal of Pediatrics.Perry E. Rosen, from the New Jersey Poison Information and Education System in Newark, and colleagues analyzed 230 pediatric opioid exposures (among children aged 1 month through 6

HealthDay 08 October at 04.12 PM

Social Risk Factors Tied to Lower Odds of Receiving Preventive Services

Social risk factors are associated with decreased odds of receiving preventive services such as mammograms, Papanicolaou (Pap) tests, flu or pneumococcal vaccines, and colonoscopies, according to a study published online Oct. 4 in&nbsp;JAMA Network Open.Tamara Schroeder, M.D., from the University of California, Davis, and colleagues exa

HealthDay 08 October at 04.05 PM

Cilta-Cel Treatment Safe, Effective for Relapsed/Refractory Multiple Myeloma

Ciltacabtagene autoleucel (cilta-cel) CAR T-cell therapy for relapsed/refractory multiple myeloma (RRMM) results in a deep and durable response, according to a study published online Oct. 4 in&nbsp;Blood.Surbhi Sidana, M.D., from Stanford University in California, and colleagues reported outcomes with cilta-cel in the standard-of-care s

HealthDay 08 October at 03.54 PM

Many Patients Expecting Antibiotics for Common Symptoms Lack Knowledge of Risk

Lack of knowledge of antibiotic risks contributes to primary care patients' expectations of antibiotics for common symptoms, according to a study published online in the September/October issue of the&nbsp;Annals of Family Medicine.Lindsey A. Laytner, Ph.D., from the Baylor College of Medicine in Houston, and colleagues conducted a surv

HealthDay 07 October at 09.21 PM

Metabolic Risk Contributes to Diabetes Onset in People With HIV

For people with HIV (PWH) with low-to-moderate atherosclerotic cardiovascular disease (ASCVD) risk, metabolic risk factors contribute to new-onset diabetes mellitus (DM) among those treated with pitavastatin or placebo, according to a study published online Oct. 8 in the Annals of Internal Medicine.Kathleen V. Fitch, from Massachusetts G

HealthDay 07 October at 04.08 PM

One-Dose HPV Vaccination Averts Similar Number of Cancers as Two Doses

A one-dose human papillomavirus (HPV) vaccination program is projected to prevent a similar number of cervical cancers as a two-dose program, according to a study published online Oct. 7 in CMAJ, the journal of the Canadian Medical Association.Mélanie Drolet, Ph.D., from the Université Laval in Québec City, and colleagues used an individ

HealthDay 07 October at 04.02 PM

Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis Suppurativa

For patients with hidradenitis suppurativa (HS), bimekizumab is safe and efficacious over two years, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Christos C. Zouboulis, from the European Hidradenitis Suppurativa Foundation in Dessau, Germany, and

HealthDay 07 October at 03.53 PM

Liso-Cel Has Favorable Safety Profile for Outpatients With Large B-Cell Lymphoma

For patients with relapsed/refractory large B-cell lymphoma (LBCL), the autologous, CD19-directed, 4-1BB chimeric antigen receptor T-cell product, lisocabtagene maraleucel (liso-cel), is safe for outpatients and inpatients and is efficacious, according to a study published online Sept. 30 in Blood Advances.Yuliya Linhares, M.D., from the

HealthDay 07 October at 03.47 PM

CHEST: Dupilumab for COPD Tied to Improvement in Health-Related Quality of Life

Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, according to a study presented at CHEST 2024, the annual meeting of the American College of Chest Physicians, held from Oct. 6 to 9 in Boston.&nbsp;Surya P. Bhatt, M.D., from the University of Alabama at

HealthDay 04 October at 09.15 PM

Immunity From Mpox Vaccine May Be Waning

Immunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jynneos) vaccine, according to a research letter published online Oct. 3 in the Journal of the American Medical Association.Ai-ris Y. Collier, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues as

HealthDay 04 October at 03.27 PM

Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema

For patients with moderate-to-severe atopic dermatitis (AD), lebrikizumab has long-term efficacy, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Diamant Thaçi, Ph.D., from University Lübeck in Germany, and colleagues reported long-term efficacy and

HealthDay 04 October at 03.18 PM

GLP-1 RA Use Linked to Retained Gastric Contents During Endoscopies

Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures, according to a research letter published online Oct. 1 in JAMA Network Open.Jason Nasser, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagu

HealthDay 04 October at 03.15 PM

Anti-TL1A Monoclonal Antibody, Tulisokibart, Aids Ulcerative Colitis

Tulisokibart, a tumor necrosis factor-like cytokine 1A monoclonal antibody, is more effective in inducing clinical remission in patients with moderately to severely active ulcerative colitis than placebo, according to a phase 2 study published in the Sept. 26 issue of the&nbsp;New England Journal of Medicine.Bruce E. Sands, M.D., from th

HealthDay 03 October at 10.14 PM

CDC: Counterfeit Drugs From Online Pharmacies Pose Considerable Danger

Counterfeit medications from online pharmacies pose significant risks to patients, including overdose and death, according to a warning issued by the U.S. Centers for Disease Control and Prevention.The warning follows a federal indictment announced last week again

HealthDay 03 October at 03.40 PM

Rheumatoid Arthritis Tied to Heavy Economic and Human Burdens

Rheumatoid arthritis (RA) is associated with higher health care expenditures and suboptimal quality of life in U.S. adults, according to a study published online Aug. 6 in&nbsp;ACR Open Rheumatology.Yinan Huang, Ph.D., from the University of Mississippi in Oxford, and colleagues estimated the economic and humanistic burden of RA among

HealthDay 03 October at 11.18 AM

Record Rate of U.S. Kindergartners Failed to Get Recommended Vaccines

In yet another sign that childhood vaccinations can't be taken for granted, new government data show that a record number of kindergartners were exempted from the required shots during the last school year.That leaves more than 125,000 new students without the protection of at least one childhood vaccine, even as measles vaccination rates among

HealthDay 02 October at 03.11 PM

Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea

Olanzapine may be better than prochlorperazine for reducing refractory nausea in patients with breast cancer starting a high/moderate emetogenic chemotherapy regimen, according to a study presented at the American Society of Clinical Oncology annual Quality Care Symposium, held from Sept. 27 to 28 in San Francisco.&nbsp;Luke Joseph Peppone, Ph

HealthDay 02 October at 02.54 PM

Higher Buprenorphine Doses Reduce Acute Care for Opioid Use Disorder

Higher doses of buprenorphine for patients with opioid use disorder (OUD) are associated with lower acute care utilization, according to a study published online Sept. 25 in&nbsp;JAMA Network Open.Sarah Axeen, Ph.D., from the University of Southern California in Los Angeles, and colleagues examined the association between higher bupre

HealthDay 02 October at 02.51 PM

First-Trimester Iron Screening Can ID Women at Risk for Later Deficiency

Screening pregnant women during their first trimester with a target ferritin concentration of &gt;60 μg/L may identify those at risk for iron deficiency later in pregnancy, according to a study published online Sept. 26 in the&nbsp;American Journal of Clinical Nutrition.Elaine K. McCarthy, Ph.D., from University College Cork in Irelan

HealthDay 01 October at 10.48 PM

FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.The approval was based on results from two pivotal phase 3 trials (BOREAS and NOTUS) that evaluated Dupixent (468 and 470 par

HealthDay 01 October at 10.45 PM

2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer

The 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presented at the American Society of Clinical Oncology annual Quality Care Symposium, held from Sept. 27 to 28 in San Francisco.Puneeth Indurlal, M.D., from the U.S. Onco

HealthDay 30 September at 10.15 PM

FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C

The U.S. Food and Drug Administration has approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, in combination with the enzyme inhibitor miglustat, is approved to treat neurological symptoms associated with NPC in adults and children aged 2 years and older. The approval received pr

HealthDay 30 September at 04.14 PM

Guideline Developed for Opioid Prescribing in Children With Acute Pain

In a clinical practice guideline issued by the American Academy of Pediatrics and published online Sept. 30 in Pediatrics, recommendations are presented for opioid prescribing for acute pain management in children and adolescents in outpatient settings.Scott E. Hadland, M.D., M.P.H., from Harvard Medical School in Boston, and colleague

HealthDay 30 September at 04.09 PM

Event-Free Survival Extended With Long-Term Finerenone in Heart Failure

Long-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief report published online Sept. 27 in JAMA Cardiology to coincide with the annual meeting of the Heart Failure Society of America, held virtually from Sept. 27 to

HealthDay 30 September at 04.04 PM

Measles Cases in England Consistent With Waning of Vaccine Immunity

Measles cases in England are consistent with the waning of vaccine-induced immunity, according to a study published online Sept. 26 in The Lancet Public Health.Alexis Robert, Ph.D., from the London School of Hygiene &amp; Tropical Medicine, and colleagues examined whether measles dynamics observed in England between 2010 and 2019 were

HealthDay 30 September at 04.01 PM

1999 to 2020 Saw Decline in Menopausal Hormone Therapy Use

From 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) use among postmenopausal women, according to a study published online Sept. 27 in JAMA Health Forum.Lin Yang, Ph.D., from Cancer Care Alberta in Calgary, Canada, and colleagues examined trends in and correlates of MHT use among postmenopausal women in the Unite

HealthDay 27 September at 10.41 PM

More Than Half of Infants Protected by Maternal RSV Vaccine, Nirsevimab, or Both

In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research published in the Sep. 26 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Hilda Razzaghi, Ph.D., from the CDC in Atl

HealthDay 27 September at 04.03 PM

Metabolic Surgery Is Renoprotective in Patients With Obesity, CKD

For patients with obesity, type 2 diabetes, and estimated glomerular filtration rate (eGFR) 20 to 60 mL/min/1.73 m2, metabolic surgery is associated with a lower risk for progression of kidney impairment compared with glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment, according to a study published in the September issue of the <

HealthDay 27 September at 04.00 PM

Aggressive, Early Disease-Modifying Therapy May Slow MS Progression

Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression, according to a study presented at the annual meeting of the American Neurological Association, held Sept. 14 to 17 in Orlando, Florida.Jack Reeves, Ph.D., from State University of New York at Buffalo, and colleagues assessed the

HealthDay 27 September at 03.52 PM

Ziresovir Reduces Signs, Symptoms of Bronchiolitis in Babies With RSV

For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study published in the Sept. 26 issue of the New England Journal of Medicine.Shunying Zhao, M.D., Ph.D., from Beijing Children's Hospital, and colleagues enrolled participan

HealthDay 27 September at 10.19 AM

FDA Approves New Kind of Drug for Schizophrenia

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration.Cobenfy (xanomeline/trospium chloride) could bring patients what they've long hoped for: A means of easing the hallucinations and "voices" that disrupt their lives without the weight gain and sluggish

HealthDay 26 September at 10.28 PM

Childhood Vaccination Coverage Lower for Children Born in 2020, 2021

Children born in 2020 to 2021 had lower coverage with nearly all childhood vaccines recommended by age 24 months than those born in 2018 and 2019, according to research published in the Sep. 26 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Holly A. Hill, M.D., Ph.D., from the CDC i

HealthDay 26 September at 10.27 PM

Free COVID-19 Tests Available Now

The free COVID-19 tests promised by the U.S. government are now available."U.S. households will be eligible to order four free COVID-19 tests at COVIDTests.gov," according to the U.S. Department of Health and Human Services. "The COVID-19 tests will detect current COVID-19 variants and can be used through the end of the year."More than

HealthDay 26 September at 04.22 PM

FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS

The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis (MS).The injection is administered by a health care professional. Patients are given premedications at least 30

HealthDay 26 September at 04.01 PM

FDA Approves Bimzelx for Three New Indications

The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation, and adults with active ankylosing spondylitis (AS).Bimzelx selectively inhibits two key cyt

HealthDay 26 September at 03.38 PM

Anti-CD20 Therapy Shows No Effect on Disability Progression in MS

For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does not differ for those who are anti-CD20-treated and untreated, according to a study published online Sept. 25 in Neurology.Marion Hay, M.D., from Rennes University Hospital in France, and colleagues analyzed CDP in

HealthDay 25 September at 10.25 PM

Federal Government to Offer More Free COVID-19 Tests

The U.S. government is offering another round of free COVID-19 tests, which will be available by the end of September."U.S. households will be eligible to order four free COVID-19 tests at COVIDTests.gov," according to the U.S. Department of Health and Human Services. "The COVID-19 tests will detect current COVID-19 variants and can be used

HealthDay 25 September at 03.47 PM

Semaglutide May Lower Risk for Opioid Overdose in T2DM, Opioid Use Disorder

For patients with type 2 diabetes (T2D) and opioid use disorder (OUD), semaglutide is associated with a significantly lower risk for opioid overdose compared with other antidiabetic medications, according to a research letter published online Sept. 25 in JAMA Network Open.William Wang, from the Case Western Reserve University School

HealthDay 25 September at 03.42 PM

Early Adoption of DOAC Dashboard Reduces Off-Label Prescribing

Early adoption of the direct oral anticoagulant (DOAC) population management dashboard, the purpose of which includes pharmacist review and correction of off-label dosing prescriptions, is associated with reduced rates of off-label DOAC dosing prescription and reduced bleeding, according to a study published online Sept. 9 in the Journal of the

HealthDay 25 September at 03.40 PM

Semaglutide Beneficial for Hidradenitis Suppurativa in Patients With Obesity

For patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields improvement in quality of life and a reduction in flares, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Daniel Lyons, M.D., fro

HealthDay 25 September at 01.00 PM

Most Americans Won't Get Vaccinated as Flu, COVID Season Looms: Survey

Most Americans don’t plan to get vaccinated against the flu or COVID-19 this season, a new survey has found.Fewer than two in five U.S. adults (38%) say they will definitely get a flu jab, and only one in four (26%) say they’ll get the updated COVID v

HealthDay 25 September at 11.31 AM

Novo Nordisk CEO Grilled by Congress Over Price of Ozempic

During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its blockbuster drugs Ozempic and Wegovy.While testifying before the Senate Commit

HealthDay 24 September at 11.00 PM

Few U.S. Jails Offer Medications for Opioid Use Disorder

Few U.S. jails offer medications for opioid use disorder (MOUD), according to a study published online Sept. 24 in JAMA Network Open.Elizabeth Flanagan Balawajder, M.P.H., from NORC at the University of Chicago, and colleagues examined the prevalence of MOUD in U.S. jails and the association of jail- and county-level factors with MOUD

HealthDay 24 September at 10.58 PM

14 Percent of U.S. Adults Meet Criteria for Absolute Iron Deficiency

A considerable proportion of U.S. adults has absolute and functional iron deficiency, according to a study published online Sept. 24 in JAMA Network Open.Yahya M.K. Tawfik, Pharm.D., from Brigham and Women's Hospital in Boston, and colleagues conducted a cross-sectional study analyzing data from the National Health and Nutritional Exa

HealthDay 24 September at 03.07 PM

Skeletal Muscle Relaxants Beneficial for Only Certain Conditions

Long-term use of skeletal muscle relaxants (SMRs) for chronic pain is only effective for certain conditions, such as painful spasms, painful cramps, and neck pain, according to a review published online Sept. 19 in&nbsp;JAMA Network Open.Benjamin J. Oldfield, M.D., from the Yale School of Medicine in New Haven, Connecticut, and collea

HealthDay 24 September at 03.03 PM

UBE Microdiscectomy Beneficial for Lumbar Disc Herniation

For adults with symptomatic lumbar disc herniation, unilateral biportal endoscopic (UBE) microdiscectomy is associated with longer operating times and with lower pain medication consumption in the early postoperative period compared with tubular lumbar microdiscectomy, according to a study published online Sept. 19 in Blood.Charla Fis

HealthDay 23 September at 10.26 PM

Review Compares Drug Interventions for Acute Migraine Treatment

All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for the acute treatment of migraine among adults, according to a review published online Sept. 18 in The BMJ.William K. Karlsson, from the Danish Headache Centre&nbsp;at Copenhagen University Hospital-Rigshospitalet

HealthDay 23 September at 03.53 PM

Pomalidomide Efficacious in Hereditary Hemorrhagic Telangiectasia

For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis severity, according to a study published in the Sept. 19 issue of the New England Journal of Medicine.Hanny Al-Samkari, M.D., from Massachusetts General Hospital in Boston, and colleagues conducted a randomized, place

HealthDay 23 September at 03.50 PM

High Response Incidence Seen for Axatilimab in Recurrent, Refractory GVHD

For patients with recurrent or refractory graft-versus-host disease (GVHD), the colony-stimulating factor 1 receptor (CSF1R)-blocking antibody axatilimab results in a high incidence of overall response, according to a study published in the Sept. 19 issue of the New England Journal of Medicine.Daniel Wolff, M.D., from University Hospit

HealthDay 23 September at 03.42 PM

Paternal Antiseizure Rx Use at Conception Does Not Pose Risk to Offspring

Limited data indicate that paternal exposure to antiseizure medications (ASMs) at conception is unlikely to pose any major risk for adverse outcomes for offspring, according to a review published online Sept. 17 in the Journal of Neurology, Neurosurgery &amp; Psychiatry.Eliza Honybun, from the University of Melbourne in Australia, and

HealthDay 20 September at 10.59 PM

No Perinatal Risks Seen With Influenza Vaccination in Successive Pregnancies

Influenza vaccination in successive pregnancies is not associated with increased risk for prespecified adverse perinatal outcomes, according to a study published online Sept. 19 in JAMA Network Open.Darios Getahun, M.D., Ph.D., M.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues conducted a retrospective coho

HealthDay 20 September at 10.58 PM

FDA Approves First Flu Vaccine That Can Be Self-Administered at Home

On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home.It is a "new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility, and accessibility for individuals and families," Peter Marks, M.D., director of the FDA Center fo

HealthDay 20 September at 03.58 PM

In 2021, More Than 1 Million Deaths Attributed to Antimicrobial Resistance

From 1990 to 2021, the burden of antimicrobial resistance (AMR) decreased for those younger than 5 years and increased for those older than 70 years, according to a study published online Sept. 16 in The Lancet.Mohsen Naghavi and colleagues from the GBD 2021 Antimicrobial Resistance Collaborators estimated all-age and age-specific deat

HealthDay 20 September at 03.50 PM

Behavior Change Intervention Via Mail Cuts Use of Sleep Medications in Older Adults

A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia, according to a study published online Sept. 18 in&nbsp;JAMA Psychiatry.David M. Gardner, Pharm.D., from Dalhousie University in Halifax, Nova Scotia, Canada, and colleagues compared

HealthDay 20 September at 03.42 PM

Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy

For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, including one immune checkpoint inhibitor (ICI), tivozanib has efficacy, according to a study published online Sept. 13 in The Lancet to coincide with the annual meeting of the European Society for Medical Oncology, held

HealthDay 20 September at 03.29 PM

Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer

Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk muscle-invasive urothelial carcinoma after radical surgery, according to a study published online Sept. 18 in the New England Journal of Medicine to coincide with the annual meeting of the European Society for Medical Oncol

HealthDay 20 September at 12.06 PM

FDA Says Drug Makers Will Stop Producing Fentanyl 'Lollipops'

Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced.Known as TIRF medications, these products contain fentanyl and are used to manage breakthrough pain in cancer patients who have become tolerant to around-the-clock opioid therapy, the FDA said in a <a

HealthDay 20 September at 11.15 AM

U.S. Whooping Cough Cases Rising, Especially in Teens, CDC Says

Whooping cough cases are climbing at the fastest pace in years as students across America return to school, U.S. health officials reported Thursday.In figures&nbsp;published by the U.S. Centers for Disease Control and Prevention, a total of 291 cases were reported

HealthDay 19 September at 10.12 PM

Improvement Seen in Vaccine Completion Among Military Children

Among military children, there has been an improvement in vaccine completion and timeliness, but the risk for noncompletion is higher among children born to younger parents and those with a well-child care location change, according to a study published online Sept. 19 in Pediatrics.Celeste J. Romano, from the Naval Health Research C

HealthDay 19 September at 10.10 PM

Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer

For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab yields a significant improvement in overall survival compared with neoadjuvant chemotherapy alone, according to a study published online Sept. 15 in the New England Journal of Medicine to coincide with

HealthDay 19 September at 03.57 PM

Metformin Use Tied to Lower Incidence of Death, Long COVID After COVID-19

After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2 (PASC), according to a study published online Sept. 17 in Diabetes Care.Steven G. Johnson, Ph.D., from the University of Minnesota in Minneapo

HealthDay 19 September at 03.51 PM

Mild Initial Clinical Course Seen for COVID-19 Vaccine-Linked Myocarditis

COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October issue of eClinicalMedicine.Supriya S. Jain, M.D., from New York Medical College-Maria Fareri Children's Hospital at Westchester Medical Center in Valhalla, and colle

HealthDay 19 September at 03.35 PM

Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer overall and progression-free survival, according to a study published online Sept. 13 in the New England Journal of Medicine to coincide with the annual meeting of the European Society for Medical Oncology, held from Sept.

HealthDay 19 September at 03.31 PM

Long-Term Survival Benefit Seen for Nivolumab in Advanced Melanoma

For patients with advanced melanoma, there is a survival benefit for nivolumab plus ipilimumab and for nivolumab monotherapy compared with ipilimumab monotherapy, according to a study published online Sept. 15 in the New England Journal of Medicine to coincide with the annual meeting of the European Society for Medical Oncology, held from S

HealthDay 18 September at 10.22 PM

FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis

The U.S. Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.The targeted interleukin-13 inhibitor is administered via a 250-mg/2 mL injection with or without topical corticosteroids in patients with atopic dermatitis not well controll

HealthDay 18 September at 03.46 PM

Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine

Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine (CM) and MOH, according to a study published online Sept. 16 in JAMA Neurology.Stewart J. Tepper, M.D., from the New England Institute for Neurology and Headache in St

HealthDay 18 September at 03.41 PM

Discrepancies Seen Between Young People's Preferred, Actual Sources of Contraceptive Info

There are discrepancies between preferred and actual sources of contraceptive information for U.S. adolescents and young adults (AYA), according to a research letter published online Sept. 13 in&nbsp;JAMA Network Open.Elizabeth Pleasants, Dr.P.H., from the University of California, Berkeley, and colleagues examined AYAs’ preferred a

HealthDay 18 September at 11.05 AM

FDA Expands Use of Breast Cancer Drug Kisqali

Women with early-stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced Tuesday.“The FDA approval of Kisqali for this early breast cancer p

HealthDay 18 September at 09.48 AM

Cost Has Many Going Around Doctors to Get Weight-Loss Medications

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, and often too expensive to afford without insurance coverage.Because of these barriers, many people are doing an end-run around t

HealthDay 17 September at 09.20 PM

Postpartum Anxiety, Depression Not Up After Pandemic Onset, but Benzodiazepine Rx Increased

Among privately insured women, diagnoses of postpartum anxiety and depression did not increase following onset of the COVID-19 pandemic, but there was an increase in the proportion of women filling a benzodiazepine prescription, according to a study published online June 24 in the Archives of Women's Mental Health.Grace Bagwell Adams,

HealthDay 17 September at 09.13 PM

Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients

For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with the risk for coronary artery calcium (CAC), according to a study published online Sept. 17 in the Canadian Journal of Cardiology.Yu Hiasa, M.D., from the Ehime University Graduate School of Medicine in Toon, Japan,

HealthDay 17 September at 03.23 PM

Rx Amphetamine Use Linked to Increased Odds of Psychosis, Mania

Past-month prescription amphetamine use is associated with increased odds of psychosis and mania, with increased odds for high doses (&gt;30 mg dextroamphetamine equivalents), according to a study published online Sept. 12 in The American Journal of Psychiatry.Lauren V. Moran, M.D., M.P.H., from McLean Hospital in Belmont, Massachuset

HealthDay 17 September at 03.05 PM

One-Dose MVA-BN Vaccine Moderately Effective Against Mpox

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities, according to a study published online Sept. 11 in The BMJ.Christine Navarro, M.D., from Public Health Ontario in Toronto, and colleagues estimated the real-world effectiveness of the MVA-BN vacci

HealthDay 17 September at 02.58 PM

GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, Diabetes

For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for cirrhosis and for cirrhosis complications and mortality, according to a study published online Sept. 16 in JAMA Internal Medicine.Fasiha Kanwal,

HealthDay 16 September at 10.23 PM

FDA Approves Tremfya for Ulcerative Colitis

The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.Tremfya is the first and only dual-acting interleukin-23 inhibitor approved in active ulcerative colitis. It is approved for administration as a 200-mg induction dose intravenously at weeks 0,

HealthDay 16 September at 03.45 PM

Rx Up for Stimulants and Antidepressants, Down for Opioids, 2019 to 2022

Overall prescription volumes for stimulant and antidepressant medications increased from 2019 to 2022, while prescription volume for opioids decreased, according to a study published online Sept. 13 in&nbsp;JAMA Network Open.Ashwini Nagappan, from University of California, Los Angeles, and colleagues characterized in-person and telehea

HealthDay 13 September at 03.35 PM

Once-Weekly Efsitora Noninferior to Degludec for Type 2 Diabetes

Once-weekly efsitora is noninferior to once-daily degludec for reducing glycated hemoglobin levels in adults with type 2 diabetes who have not received insulin, according to a study published online Sept. 10 in the New England Journal of Medicine to coincide with the annual meeting of the European Association for the Study of Diabetes, held f

HealthDay 13 September at 02.44 PM

Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC

Tusamitamab ravtansine (tusa rav), an immunoconjugate, does not improve progression-free survival (PFS) in patients with previously treated advanced nonsquamous non-small cell lung cancer (NSCLC), according to a study presented at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer, held from Sept. 7 to 10 i

HealthDay 13 September at 02.38 PM

Many U.S. Adults With Uncontrolled HTN Are Unaware of HTN Status

More than half of adults with uncontrolled hypertension are unaware that they have hypertension, according to a study published online Sept. 11 in JAMA Network Open.LaTonia C. Richardson, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined the prevalence of hypertension control cascade ou

HealthDay 12 September at 09.31 PM

Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer

For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is the preferred total neoadjuvant therapy (TNT) regimen, according to a study published online Sept. 11 in the Annals of Oncology to coincide with the European Society for Medical Oncology Congress 2024, being held from Sept.

HealthDay 12 September at 04.18 PM

2017 to 2022 Saw Increase in Naloxone Prescribing Among Adolescents

From 2017 to 2022, there was an increase in naloxone prescribing among adolescents, with pediatricians accounting for an increasing proportion of prescriptions dispensed, according to a study published online Sept. 12 in Pediatrics.Andrew Terranella, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, a

HealthDay 12 September at 04.14 PM

Liraglutide Efficacious, Safe for Children Aged 6 to <12 Years

Liraglutide plus lifestyle intervention is efficacious for children aged 6 to &lt;12 years with obesity, according to a study published online Sept. 10 in the New England Journal of Medicine to coincide with the European Association for the Study of Diabetes Congress, held Sept. 9 to 13 in Madrid.Claudia K. Fox, M.D., from the Univer

HealthDay 12 September at 04.10 PM

Racial Differences Seen in Pain Rx for Older Adults With Hip Fracture

Racial differences exist in opioid pain management for Medicare beneficiaries after a hip fracture, according to a study published online Sept. 11 in the&nbsp;Journal of the American Geriatrics Society.Kaleen N. Hayes, Pharm.D., Ph.D., from Brown University in Providence, Rhode Island, and colleagues assessed whether the receipt and

HealthDay 12 September at 03.59 PM

Perioperative Nivolumab Beneficial for Resectable NSCLC

For patients with resectable non-small-cell lung cancer (NSCLC), perioperative nivolumab is associated with event-free survival (EFS) benefit compared with neoadjuvant nivolumab, according to a study presented at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer, held from Sept. 7 to 10 in San Diego.

HealthDay 12 September at 03.51 PM

Statin Therapy Cost-Effectively Improves Health Outcomes for ≥70s

Statin therapy improves health outcomes and is cost-effective for men and women aged 70 years and older, according to a study published online Sept. 10 in Heart.Borislava Mihaylova, D.Phil., from the University of Oxford in the United Kingdom, and colleagues examined the long-term effects and cost-effectiveness of statin therapy for

HealthDay 12 September at 09.47 AM

Many Americans Wary of Vaccines as Fall Flu, COVID Season Looms: Survey

A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds.More than one-third of those polled (37%) said they’d gotten vaccines in the past but don’t plan to this year, according to results from a nationwide Ohio State

HealthDay 11 September at 03.40 PM

Quadruple Single Pill Superior for Resistant Hypertension

For patients with resistant hypertension, a quadruple single pill is superior to triple therapy, according to a study presented at the European Society of Cardiology Congress, held from Aug. 30 to Sept. 2 in London.Stefano Taddei, from the University of Pisa in Italy, and colleagues conducted a double-blind, randomized trial involving patien

HealthDay 11 September at 03.36 PM

Use of Nose Drops Reduces Length of Young Children’s Colds

Hypertonic saline (HS) nose drops reduce the duration of symptoms associated with viral upper respiratory tract infections (URTI) in children, according to a study presented at the European Respiratory Society Congress, held from Sept. 7 to 11 in Vienna.Steve Cunningham, from&nbsp;University of Edinburgh in Scotland, and colleagues investiga

HealthDay 11 September at 03.33 PM

Many Women Continue Using Menopausal Hormone Therapy Beyond Age 65 Years

Many women older than 65 years have validated menopausal symptoms severely affecting their quality of life and continue to use menopausal hormone therapy (MHT), according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.Meenakshi Goel, M.D., from University of Toronto, and colleagues ex

HealthDay 11 September at 03.27 PM

Hormone Tx Tied to Reductions in Insulin Resistance

Hormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women, according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.Tanya Li, from Reading Hospital Tower Health in West Reading, Pennsylvania, and colleagues conducted a systematic

HealthDay 10 September at 10.32 PM

2007 to 2023 Saw Decline in Menopausal Hormone Therapy Usage Rates

Menopausal hormone therapy (HT) usage rates declined from 2007 to 2023 and remain low, according to a study presented at the annual meeting of The Menopause Society, held from Sept. 10 to 14 in Chicago.Mariam Saadedine, M.D., from the Mayo Clinic in Jacksonville, Florida, and colleagues described systemic menopausal HT utilization in women age

HealthDay 10 September at 10.19 PM

Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer

Omission of 5-fluorouracil (5-FU) from the first-line FOLFOX, FOLFIRI, and FOLFIRINOX regimens is not associated with reduced survival among patients with advanced colorectal, gastroesophageal, and pancreatic cancers, according to a study published online Sept. 5 in the Journal of the National Comprehensive Cancer Network.Chengwei Pen

HealthDay 10 September at 10.13 PM

Depemokimab Cuts Exacerbation Rate in Eosinophilic Asthma

For patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, according to a study published online Sept. 9 in the New England Journal of Medicine to coincide with the European Respiratory Society Congress, held from Sept. 7 to 11 in Vienna.David J. Jackson, Ph.D., from King'

HealthDay 10 September at 04.00 PM

Low-Dose Triple-Pill Protocol Lowers BP in Black Africans With Hypertension

For Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieves better blood pressure lowering and control than standard care, according to a study published online Aug. 31 in the Journal of the American Medical Association to coincide with the European Society of Cardiology Congress 2024, held from Aug. 30

HealthDay 10 September at 03.45 PM

Timing of Blood Pressure Meds Has No Impact on Outcomes

Taking blood pressure (BP) medications in the morning or at night does not impact outcomes, according to a study presented at the annual meeting of the European Society of Cardiology, held Aug. 30 to Sept. 2 in London.Scott Garrison, M.D., Ph.D., from University of Alberta in Edmonton, Canada, and colleagues evaluated whether bedtime use of BP

HealthDay 10 September at 03.35 PM

Review Weighs Treatments for Genitourinary Symptoms of Menopause

Vaginal estrogen, vaginal dehydroepiandrosterone (DHEA), oral ospemifene, and vaginal moisturizers may be beneficial for some genitourinary symptoms of menopause (GSM), according to a review published online Sept. 10 in the Annals of Internal Medicine.Elisheva R. Danan, M.D., M.P.H., from the University of Minnesota in Minneapolis, an

HealthDay 09 September at 03.56 PM

Polypharmacy Common in Medicaid-Enrolled Youth With Behavioral and Mental Health Diagnoses

Contraindicated drug pairs are uncommon in youth with Medicaid coverage filling combinations of behavioral and mental health (BMH) medications, according to a study published online July 30 in&nbsp;BMC Primary Care.Laura M. Borgelt, Pharm.D., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues characterized

HealthDay 09 September at 03.45 PM

Empagliflozin Confers Kidney-Protective Benefits After Acute MI

Empagliflozin confers kidney-protective benefits for patients with acute myocardial infarction (MI) and an increased risk for heart failure, according to a study presented at the European Society of Cardiology Congress 2024, held from Aug. 30 to Sept. 2 in London.Rahul Aggarwal, M.D., from Harvard Medical School in Boston, and colleagues conduct

HealthDay 06 September at 09.57 PM

6.7 Percent of U.S. Adults Cannot Use Automatic BP Devices Due to Arm Size

An estimated 6.7 percent of U.S. adults cannot use popular automatic blood pressure devices due to arm circumference, according to a research letter published online Sept. 5 in&nbsp;Hypertension&nbsp;to coincide with the American Heart Association Hypertension 2024 Scientific Sessions, held from Sept. 5 to 8 in Chicago.Eileen Kaur, from

HealthDay 06 September at 09.37 PM

Socioeconomic Disparities Impact Immunotherapy Use in Urologic Cancers

Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with advanced clear cell renal cell carcinoma (ccRCC) and urothelial carcinoma of the bladder (UC), according to a study published in the November issue of Urologic Oncology: Seminars and Original Investigations.Levi Holl

HealthDay 06 September at 03.45 PM

Machine Learning Can ID Risk for Persistent Opioid Use After Surgery

Machine learning can identify patients who are at risk for persistent opioid use after surgery, according to a study published in the September issue of Plastic and Reconstructive Surgery.Natalie B. Baxter, from the University of Michigan Medical School in Ann Arbor, and colleagues trained two algorithms to predict persistent opioid use

HealthDay 06 September at 03.09 PM

Adjunctive IV Argatroban, Eptifibatide Do Not Cut Disability After Stroke

Adjunctive treatment with intravenous argatroban or eptifibatide does not reduce poststroke disability among patients with acute ischemic stroke treated with intravenous thrombolysis within three hours after symptom onset, according to a study published in the Sept. 5 issue of the New England Journal of Medicine.Opeolu Adeoye, M.D., fro

HealthDay 05 September at 10.41 PM

Lower Uptake of HPV Vaccine Seen for Girls With Mental Illness

Girls with mental illness and neurodevelopmental conditions have lower uptake of human papillomavirus (HPV) vaccination, according to a study published in the September issue of The Lancet Public Health.Kejia Hu, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a population-based cohort study to examine the

HealthDay 05 September at 10.38 PM

Doxorubicin + Trabectedin Tied to Increased Survival in Metastatic Leiomyosarcoma

For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival compared with doxorubicin alone, according to a study published online Sept. 4 in the New England Journal of Medicine.Patricia Pautier, M.D., fro

HealthDay 05 September at 10.35 PM

RSV Vaccination Effective Against Hospitalization in Patients 60 Years and Older

For older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a study published online Sept. 4 in the Journal of the American Medical Association.Diya Surie, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined RSV vaccine effectiven

HealthDay 05 September at 03.06 PM

Report Reveals Extent of Cost-Related Medication Nonadherence in Seniors

About 3.5 percent of older adults do not take prescription medications due to cost and a similar percentage do not take medications as prescribed due to cost, according to a study published online Sept. 5 in the&nbsp;National Health Statistics Reports, a publication from the National Center for Health Statistics.Robin A. Cohen, Ph.D.,

HealthDay 05 September at 10.23 AM

Amid Shortages, U.S. Allows Expanded Production of ADHD Drug Vyvanse

The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues.Following a request from the U.S. Food and Drug Administration in July, the DE

HealthDay 04 September at 11.06 PM

Monoclonal Antibody Tops Placebo for Reducing Migraine Frequency

The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing migraine frequency over four weeks, according to a study published in the Sept. 5 issue of the New England Journal of Medicine.Messoud Ashina, M.D., from Copenhagen

HealthDay 04 September at 03.10 PM

First-Generation Antihistamines Increase Risk for Seizures in Children

First-generation antihistamines are associated with a higher seizure risk in young children, according to a study published online Aug. 28 in&nbsp;JAMA Network Open.Ju Hee Kim, M.D., from the Kyung Hee University Medical Center in Seoul, South Korea, and colleagues evaluated associations between prescriptions of first-generation anti

HealthDay 04 September at 03.06 PM

Asthma Inhalers Tied to Large Greenhouse Gas Emissions Production

Inhaler devices are a substantial source of greenhouse gas emissions in the United States, according to a research letter published online Aug. 29 in the&nbsp;Journal of the American Medical Association.Jyothi Tirumalasetty, M.D., from the Stanford University School of Medicine in California, and colleagues assessed mean emissions in

HealthDay 03 September at 08.11 PM

Time From Drug Approval to Reimbursement Longer in U.S. Than Some European Countries

Time from approval to reimbursement of new drugs varies between countries and is shortest in Switzerland and Germany, both of which include health technology assessment decisions that are not used in the United States, according to a study published online Sept. 3 in the Annals of Internal Medicine.Camille E.G. Glaus, J.D., from the Un

HealthDay 03 September at 08.11 PM

SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in&nbsp;The BMJ.Anna Shin, from Seoul National University Bundang Hospital in South Korea, and colleagues compared the risk for dementia associated with SGLT-2 inhibitors versus dipe

HealthDay 03 September at 08.09 PM

Hormone Therapy Tied to Less Biological Aging in Postmenopausal Women

Postmenopausal women who use hormone therapy (HT) are biologically younger than those not receiving HT, according to a study published online Aug. 29 in&nbsp;JAMA Network Open.Yufan Liu and Chenglong Li, Ph.D., from Peking University in Beijing, evaluated the association between HT use and discrepancies between chronological and biolog

HealthDay 30 August at 10.57 PM

Home Administration of Misoprostol Safe, Effective

Home administration of misoprostol significantly increases the proportion of day-care procedures in medical abortion after 12 gestational weeks, according to a study published in the Aug. 31 issue of The Lancet.Johanna Rydelius, M.D., from the University of Gothenburg in Sweden, and colleagues evaluated whether administering the first m

HealthDay 30 August at 03.06 PM

Dietary Vitamin E May Be Protective Against Atopic Dermatitis

Dietary intake of vitamin E may potentially lower the risk for atopic dermatitis, according to a study published online Aug. 9 in&nbsp;Skin Research &amp; Technology.Siqing Wang, from the Beijing University of Chinese Medicine, and colleagues conducted a Mendelian randomization analysis to explore the causal relationship between dietary

HealthDay 29 August at 03.59 PM

Naloxone Aids Out-of-Hospital Cardiac Arrest Outcomes, Regardless of Drug Use

Regardless of drug use, administration of naloxone during out-of-hospital cardiac arrest (OHCA) is associated with improved outcomes, such as increased survival to hospital discharge, according to a study published online Aug. 20 in&nbsp;JAMA Network Open.David G. Dillon, M.D., Ph.D., from the University of California, Davis, and coll

HealthDay 29 August at 03.56 PM

Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination Myocarditis

Patients with post-COVID-19 mRNA vaccination myocarditis show a lower frequency of cardiovascular complications than those with conventional myocarditis or post-COVID-19 myocarditis at 18 months, according to a study published online Aug. 26 in the&nbsp;Journal of the American Medical Association.Laura Semenzato, from the French Natio

HealthDay 29 August at 03.46 PM

People With Xylazine Wounds Face Barriers to Seeking Wound Care

People with self-identified xylazine wounds are more likely to engage in subcutaneous injection and face several barriers to seeking medical wound treatment, according to a study published online Aug. 21 in&nbsp;Drug and Alcohol Dependence.Raagini Jawa, from the University of Pittsburgh School of Medicine, and colleagues sought to und

HealthDay 28 August at 10.04 PM

Ubrogepant Administered During Prodrome Beneficial for Migraine

For adults experiencing migraine attacks with moderate-to-severe headache pain, ubrogepant administered during prodrome is beneficial for patient-reported outcomes, according to a study published online Aug. 28 in Neurology.Richard B. Lipton, M.D., from the Albert Einstein College of Medicine in Bronx, New York, and colleagues conduc

HealthDay 28 August at 04.03 PM

RSV Infection With Inflammatory Bowel Disease Ups Risk for Hospitalization

Adult patients with inflammatory bowel disease (IBD) and respiratory syncytial virus (RSV) infection have an increased risk for hospitalization, according to a study published online in the August issue of The&nbsp;American Journal of Gastroenterology.Ryan A. Smith, M.D., from University of Wisconsin in Madison, and colleagu

HealthDay 28 August at 03.54 PM

Psilocybin Has Better Response Than Placebo in Antidepressant Trials

Patients treated with high-dose psilocybin have better responses than those treated with placebo in antidepressant trials, according to a study published online Aug. 21 in The BMJ.Tien-Wei Hsu, M.D., from E-DA Dachang Hospital in Kaohsiung, Taiwan, and colleagues examined the comparative effectiveness and acceptability of oral monoth

HealthDay 28 August at 03.04 PM

Cholinesterase Inhibitors Beneficial for Dementia With Lewy Bodies

Cholinesterase inhibitors (ChEIs) are beneficial for patients with dementia with Lewy bodies (DLB), according to a study published online Aug. 23 in Alzheimer's &amp; Dementia.Hong Xu, M.D., Ph.D., from the Center for Alzheimer Research at the Karolinska Institutet in Stockholm, and colleagues examined the impact of ChEIs and memanti

HealthDay 28 August at 03.02 PM

Increasing Thiazide Dose Linked to Greater Reduction in Calcium

For adults with kidney stones, increasing thiazide dose is associated with greater reductions in calcium, which are negatively associated with symptomatic stone events, according to a research letter published online Aug. 22 in JAMA Network Open.Ryan S. Hsi, M.D., from the Vanderbilt University Medical Center in Nashville, Tennessee,

HealthDay 28 August at 02.58 PM

Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure

Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and heart failure, according to a study published online Aug. 24 in The Lancet.John Deanfield, B.Chir., M.B., from the Institute of Cardiovascular Sciences at

HealthDay 27 August at 09.55 PM

Pharmacy Deserts Also Face Social Vulnerability, Lack of Health Care Providers

Counties with high pharmacy desert densities also face social vulnerability and health care provider shortages, according to a research letter published online Aug. 23 in&nbsp;JAMA Network Open.Giovanni Catalano, M.D., from The Ohio State University Wexner Medical Center in Columbus, and colleagues examined if pharmacy deserts dispropo

HealthDay 27 August at 09.47 PM

FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type 2 Diabetes

On Monday, the U.S. Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes. It is the first such system for use by people with the more prevalent form of the disease.The FDA first signed off on the system, which automatically adjusts insulin delivery as needed, for type 1 diabetes i

HealthDay 27 August at 03.55 PM

Lecanemab-Labeled Amyloid Plaques Identified in Down Syndrome

In middle-aged individuals with Down syndrome (DS), lecanemab-labeled amyloid plaques are seen in postmortem brain tissue analysis, in addition to extensive binding to brain blood vessels, according to a study published online Aug. 19 in JAMA Neurology.Lei Liu, M.D., Ph.D., from Brigham and Women's Hospital in Boston, and colleagues ex

HealthDay 27 August at 03.42 PM

Elinzanetant Efficacious, Well-Tolerated for Vasomotor Symptoms

For menopausal vasomotor symptoms (VMS), elinzanetant is efficacious and well-tolerated, according to a study published online Aug. 22 in the Journal of the American Medical Association.JoAnn V. Pinkerton, M.D., from the University of Virginia Health in Charlottesville, and colleagues examined the efficacy and safety of elinzanetant, a

HealthDay 27 August at 02.12 PM

Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price

Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers.The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and co

HealthDay 27 August at 10.57 AM

WHO Unveils Plan to End African Mpox Outbreak

As an mpox outbreak continues to rage in Africa, the World Health Organization on Monday launched a six-month plan to quell its spread.“The mpox outbreaks in the Democratic Republic of the Congo and neighboring countries can be controlled, and can be stopped,” WHO Director-General <a href="https://blogs.worldbank.org/en/team/t/tedros-adhanom-gh

HealthDay 26 August at 09.50 PM

After Weighting, 3.6 Million Likely to Be Newly Eligible for Semaglutide

Increases in eligibility for semaglutide are discussed in a research letter published online Aug. 27 in the Annals of Internal Medicine.After the Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity trial showed that semaglutide reduced cardiovascular events in certain patients without diabetes, Medicar

HealthDay 26 August at 09.45 PM

Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DM

For older adults with type 2 diabetes, the risk for dementia seems similar with sodium-glucose cotransporter 2 (SGLT2) inhibitors and the glucagon-like peptide 1 receptor agonist (GLP-1 RA) dulaglutide, according to a study published online Aug. 27 in the Annals of Internal Medicine.Bin Hong, from the School of Pharmacy at Sungkyunkwan

HealthDay 26 August at 09.19 PM

Most Americans Unprepared to Handle Opioid Overdoses

More than three in four people (77 percent) say they would not know how to respond if they saw someone having an opioid overdose, according to survey results from The Ohio State University."While I'm not surprised about this result, I am deeply concerned because we know that the more of us who are prepared to save a life, the more lives we can s

HealthDay 26 August at 02.26 PM

Vaccination Coverage for Teens Similar in 2023 and 2022

In 2023, vaccination coverage for adolescents with all routine vaccines was similar to coverage in 2022, according to research published in the Aug. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Cassandra Pingali, M.P.H., from the CDC in Atlanta, and colleagues analyzed data from t

HealthDay 26 August at 02.01 PM

Olaparib Monotherapy Yields Good PSA Response Rates in Prostate Cancer

For men with high-risk biochemically recurrent prostate cancer, olaparib monotherapy yields good prostate-specific antigen (PSA) response rates, especially among those with BRCA2, according to a study published online Aug. 22 in JAMA Oncology.Catherine H. Marshall, M.D., from the Johns Hopkins University School of Medicine in B

HealthDay 26 August at 10.50 AM

U.S. Will Offer Free COVID Tests By Mail by Late September

As a summer surge in COVID cases begins to ebb and Americans brace themselves for yet another wave of infections this winter, more free COVID tests will soon be available to all, federal health officials announced Friday.Starting in late September, every U.S. household can order up to four nasal swab tests when the federal program reopens, accor

HealthDay 23 August at 10.39 PM

Type 2 Diabetes Prevalence Rose in the United States From 2012 to 2022

The prevalence of diabetes increased in the United States from 2012 to 2022, according to a research letter published online July 18 in&nbsp;Diabetes, Obesity and Metabolism.Sulakshan Neupane, from the University of Georgia in Athens, and colleagues examined recent national trends and disparities in self-reported diabetes prevalence amo

HealthDay 23 August at 03.44 PM

Socially, Economically Disadvantaged Communities Lack Access to Buprenorphine

Restricted buprenorphine dispensing was most pronounced in socially and economically disadvantaged communities, according to a study published in the September issue of&nbsp;Drug and Alcohol Dependence Reports.Kyle J. Moon, from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a U.S. telephone a

HealthDay 23 August at 03.16 PM

Belzutifan Improves Progression-Free Survival in Advanced Renal Cell Cancer

Belzutifan, a hypoxia-inducible factor 2α (HIF-2α) inhibitor, improves progression-free survival and objective responses over everolimus among patients with advanced clear-cell renal cell carcinoma, according to a study published in the Aug. 22 issue of the New England Journal of Medicine.Toni K. Choueiri, M.D., from the Dana-Farber Can

HealthDay 22 August at 06.40 PM

FDA Approves Updated COVID Shots for Fall

Updated shots to shield against COVID-19 infection were approved by the U.S. Food and Drug Administration on Thursday.This year's approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall vaccines were authorized on Sept. 1

HealthDay 21 August at 03.20 PM

Semaglutide-Linked Suicidal Ideation ID'd in Disproportionality Analysis

Semaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open.Georgios Schoretsanitis, M.D., Ph.D., from Northwell Health in Glen Oaks, New York, and colleagues examined potential signals for suicidal and self-injurious adverse drug re

HealthDay 20 August at 08.49 PM

This Week Could Bring FDA Approval of Fall COVID-19 Vaccines

Updated COVID-19 vaccines may receive approval from the U.S. Food and Drug Administration this week.Two sources familiar with the issue told CNN that updated mRNA vaccines from Moderna and Pfizer that target the KP.2 variant could be greenlit as early as this week. The news agency said the sources declined to be named because informati

HealthDay 16 August at 09.19 PM

Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver Cancer

For patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does not worsen outcomes, according to research published online July 10 in the Journal of Hepatology.Mohammad Saeid Rezaee-Zavareh, from the Middle East Liver Diseases Center in Tehran, Iran, and colleagues summarized

HealthDay 16 August at 03.11 PM

Maternal Epilepsy Tied to Increased Maternal Morbidity, Perinatal Mortality and Morbidity

Women with epilepsy have a considerably higher risk for severe maternal and perinatal outcomes and an increased risk for death during pregnancy and postpartum, according to a study published online Aug. 5 in&nbsp;JAMA Neurology.Neda Razaz, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined associations between m

HealthDay 15 August at 10.00 PM

FDA Approves Nemluvio for Prurigo Nodularis

The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.Nemluvio, administered as a prefilled pen for subcutaneous injection, inhibits interleukin-31 cytokine signaling, which is known to drive itch and is involved in inflammation, altered epidermal differentiation, and fibrosi

HealthDay 15 August at 03.16 PM

ADHD Medications Also Improve Quality of Life

Medications for attention-deficit/hyperactivity disorder (ADHD) are effective at improving quality of life in people with the disorder, according to a review recently published in the&nbsp;Journal of the American Academy of Child &amp; Adolescent Psychiatry.Alessio Bellato, Ph.D., from the University of Southampton in the United Kingd

HealthDay 15 August at 03.13 PM

Problematic Pharmaceutical Opioid Use Common in Noncancer Pain

For individuals with chronic noncancer pain (CNCP) treated with opioid analgesics, problematic pharmaceutical opioid use (POU) is common, according to a study published online Aug. 7 in Addiction.Kyla H. Thomas, Ph.D., M.B.B.S., from the University of Bristol in the United Kingdom, and colleagues conducted a comprehensive systematic l

HealthDay 15 August at 11.36 AM

New Deals Will Cut Medicare Costs for Expensive Drugs

The Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.Taxpayers should save $6 billion because of the new prices, while seniors using Medicare could save roughly $1.5 billion on their medications, the U.S. Centers for

HealthDay 14 August at 10.28 PM

Vaccines for Children Program Has Increased Coverage, but Gaps Remain

The Vaccines for Children (VFC) program, which provides recommended vaccines at no cost to eligible children, has increased childhood vaccination coverage, but coverage is still lower than among non-VFC-eligible children, according to a Vital Signs report published Aug. 13 in the U.S. Centers for Disease Control and Prevention Morbidity

HealthDay 14 August at 10.22 PM

Most Patients With MS Have No Risk for Relapse After COVID-19 Vaccination

For most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in Neurology.Xavier Moisset, M.D., Ph.D., from the Universite Clermont Auvergne in Clermont-Ferrand, France, and colleagues conducted a nationwide study using data from the F

HealthDay 14 August at 03.53 PM

Past-Month Cannabis Use Increasing Among Adults With Diabetes

Among U.S. adults with diabetes, cannabis use in the past month increased by 33.7 percent from 2021 to 2022, according to a research letter published online July 22 in Diabetes Care.Benjamin H. Han, M.D., M.P.H., from the University of California, San Diego, School of Medicine in La Jolla, and colleagues estimated the most recent nat

HealthDay 14 August at 03.43 PM

Fish Oil Supplements Counteract Genetic Predisposition to High Cholesterol

Fish oil seems to counteract genetic predisposition to high cholesterol, according to a study published online July 15 in the&nbsp;American Journal of Clinical Nutrition.Yitang Sun, Ph.D., from the Franklin College of Arts and Sciences at the University of Georgia in Athens, and colleagues examined whether fish oil supplementation mo

HealthDay 14 August at 03.37 PM

Sacituzumab Govitecan Shows Promise in Advanced Endometrial Cancer

For patients with advanced endometrial cancer (EC), sacituzumab govitecan (SG), a trophoblast cell-surface antigen 2 (Trop-2)-directed antibody-drug conjugate, shows encouraging efficacy, according to a phase 2 study published online July 31 in the Journal of Clinical Oncology.Alessandro D. Santin, M.D., from the Yale School of Medic

HealthDay 12 August at 09.50 PM

GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 Diabetes

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a lower rate of renin-angiotensin system inhibitor (RASi) discontinuation compared with treatment with dipeptidyl peptidase-4 inhibitors (DPP-4is) among patients with type 2 diabetes (T2D), according to a study published online Aug. 1

HealthDay 12 August at 09.46 PM

Buprenorphine + Naloxone Safe for Opioid Addiction in Pregnancy

Pregnancies exposed to buprenorphine combined with naloxone have similar or more favorable neonatal and maternal outcomes as those exposed to buprenorphine alone, according to a study published online Aug. 12 in the Journal of the American Medical Association.Loreen Straub, M.D., from Brigham and Women's Hospital and Harvard Medical Sch

HealthDay 12 August at 04.11 PM

Risks for Mortality, Adverse Heart, Kidney Events Lower With Tirzepatide for T2DM

For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist) is associated with lower risks for all-cause mortality and adverse cardiovascular and kidney events compared with glucagon-like peptide 1 receptor agonist treatment (GLP-1 RA), according to a s

HealthDay 12 August at 03.54 PM

Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With Eczema

For patients with atopic dermatitis (AD), dupilumab maintains its clinical effectiveness up to five years and is discontinued by 23.8 percent of patients, according to a study published online Aug. 7 in JAMA Dermatology.Celeste M. Boesjes, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues examined clini

HealthDay 12 August at 03.47 PM

Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma Patients

A gene expression signature in peripheral CD4+ T-cells can predict severe immune-related adverse events (irAEs) among melanoma patients treated with ipilimumab/nivolumab, according to a study published online Aug. 8 in Clinical Cancer Research.Kelsey R. Monson, Ph.D., from the Perlmutter Cancer Center at NYU Langone Health in

HealthDay 12 August at 03.44 PM

Commonly Prescribed Antibiotics Linked to Cutaneous Adverse Drug Reactions

Sulfonamide antibiotics and cephalosporins are most strongly associated with serious cutaneous adverse drug reactions (cADRs), according to a study published online Aug. 8 in the Journal of the American Medical Association.Erika Y. Lee, M.D., from the University of Toronto, and colleagues explored the risk for serious cADRs associated w

HealthDay 12 August at 10.57 AM

FDA Says No to MDMA as Therapy for PTSD

Advocates for the use of the psychedelic drug MDMA (midomafetamine) to treat mental health conditions were delivered a setback on Friday after the U.S. Food and Drug Administration declined to approve it as treatment for post-traumatic stress disorder (PTSD).There is insufficient evidence that MDMA -- currently illegal and also known as Ecstasy

HealthDay 09 August at 03.40 PM

FDA Approves Voranigo for Grade 2 Astrocytoma or Oligodendroglioma

The U.S. Food and Drug Administration has approved Voranigo (vorasidenib) for grade 2 astrocytoma or oligodendroglioma with a susceptible mutation.The isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor is approved for adult and pediatric patients ages 12 years and older with grade 2 astrocytoma or oligodendroglioma

HealthDay 09 August at 03.34 PM

Childhood Vaccinations Have Prevented ~508 Million Lifetime Cases of Illness

Childhood vaccinations continue to provide substantial health and economic benefits, according to research published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Noting that the U.S. Vaccines for Children (VFC) program has covered the cost of vaccines for children whose

HealthDay 09 August at 03.30 PM

CDC Updates Practice Recommendations for Contraceptives

In two practice recommendations published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, updated recommendations are presented relating to use of specific contraceptive methods and for persons with certain characteristics or medical conditions.Kathryn M. Curtis, Ph.D., fr

HealthDay 08 August at 04.04 PM

Long-Acting Cabotegravir Well Tolerated in Pregnant Women

Long-acting injectable cabotegravir (CAB-LA) appears to be well tolerated in pregnant women, according to a study presented at AIDS 2024, the 25th International AIDS Conference, held from July 22 to 26 in Munich.Sinead Delany-Moretlwe, M.B.B.Ch., Ph.D., from the University of the Witwatersrand in South Africa, and colleagues reported on materna

HealthDay 08 August at 04.00 PM

Abacavir Use Linked to Increased Incidence of MACE

For patients with HIV in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) trial, use of abacavir was associated with an increased incidence of major adverse cardiovascular events (MACE), according to a study presented at AIDS 2024, the 25th International AIDS Conference, held from July 22 to 26 in Munich.Carl J. Fichtenbaum, M.

HealthDay 08 August at 03.48 PM

Interprofessional Addiction Consultation Ups Medication for Opioid Use Disorder

Interprofessional addiction consultation services significantly increase postdischarge medication for opioid use disorder (MOUD) initiation and engagement among patients with opioid use disorder, according to a study published online July 29 in&nbsp;JAMA Internal Medicine.Jennifer McNeely, M.D., from New York University Grossman School

HealthDay 07 August at 11.01 PM

Nipocalimab Can Delay, Prevent Anemia, Intrauterine Transfusion

For pregnancies at high risk for early-onset severe hemolytic disease of the fetus and newborn (HDFN), intravenous nipocalimab can delay or prevent fetal anemia or intrauterine transfusions, according to a study published online Aug. 7 in the New England Journal of Medicine.Kenneth J. Moise Jr., M.D., from Dell Medical School at the U

HealthDay 07 August at 10.55 PM

FDA Approves Darzalex Faspro for Treating Multiple Myeloma

The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for induction and consolidation in patients with newly diagnosed multiple myeloma (MM) who are eligible for an autologous stem cell transplant (ASCT).The approval was ba

HealthDay 07 August at 03.26 PM

Pharmacogenomic Score Can Personalize Treatment of Leukemia in Children

For pediatric patients with acute myeloid leukemia (AML), a pharmacogenomics-based 10 single nucleotide polymorphism cytarabine (Ara-C) score (ACS10) can be used to tailor induction regimens, yielding improved outcomes, according to a study published online July 30 in Clinical Cancer Research.Noting that low ACS10 has been shown to be

HealthDay 06 August at 11.08 PM

Many U.S. Adults Lost Trust in Physicians, Hospitals During Pandemic

U.S. adults lost trust in physicians and hospitals during the COVID-19 pandemic, according to a study published online July 31 in&nbsp;JAMA Network Open.Roy H. Perlis, M.D., from Massachusetts General Hospital in Boston, and colleagues examined how trust in physicians and hospitals changed during the COVID-19 pandemic. The analysis incl

HealthDay 06 August at 11.01 PM

FDA Approves Tecelra as First Gene Therapy for Synovial Sarcoma

The U.S. Food and Drug Administration has approved Tecelra (afamitresgene autoleucel), a gene therapy for the treatment of adults with unresectable or metastatic synovial sarcoma.Specifically, the approval is for adults who have received prior chemotherapy, are HLA-A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and have a tumor that expr

HealthDay 06 August at 03.47 PM

Aspirin-Linked Reduction in CRC Risk Varies With Lifestyle Score

Aspirin use is associated with a reduction in colorectal cancer (CRC) risk, with the greatest reduction seen among those with the unhealthiest lifestyle scores, according to a study published online Aug. 1 in JAMA Oncology.Daniel R. Sikavi, M.D., from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues ex

HealthDay 05 August at 04.10 PM

Potentially Hepatotoxic Botanicals Frequently Used in United States

An estimated 15 million U.S. adults consumed at least one of six potentially hepatotoxic botanicals within the previous 30 days, according to a study published online Aug. 5 in JAMA Network Open.Alisa Likhitsup, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues assessed the prevalence and clinical characteristics

HealthDay 05 August at 04.03 PM

2021 to 2023 Saw Considerable Increase in Semaglutide Fills

From 2021 through 2023, there was a considerable increase in the number of semaglutide fills, according to a research letter published online Aug. 2 in JAMA Health Forum.Christopher Scannell, M.D., Ph.D., from the University of Southern California in Los Angeles, and colleagues analyzed trends in prescriptions dispensed at retail pharmac

HealthDay 05 August at 03.44 PM

Monitoring Important With Antidepressants for Alcohol Use Disorder

For patients with alcohol use disorder (AUD) treated with antidepressants, those who achieve a reduction in depression symptoms have fewer relapses over time, according to a study published online July 26 in Alcohol: Clinical &amp; Experimental Research.Joshua Jaeger, from the University of Bern in Switzerland, and colleagues examined th

HealthDay 05 August at 03.37 PM

Oversight of DOAC Prescribing Beneficial for A-Fib, VTE Patients

Direct oral anticoagulant (DOAC) prescribing oversight for off-label prescribing is beneficial while patients are prescribed DOAC, according to a study published online July 30 in Thrombosis and Haemostasis.Grace C. Herron, from the Frankel Cardiovascular Center at the University of Michigan in Ann Arbor, and colleagues evaluated data fr

HealthDay 02 August at 11.01 PM

Availability Increased With Approval of Naloxone as OTC Medication

Recently, there was an increase in availability of naloxone after it was approved to be sold as an over-the-counter (OTC) medication, according to a study published online July 26 in JAMA Health Forum.Grace T. Marley, Pharm.D., from the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina, and colleagues examined whether the ac

HealthDay 02 August at 10.52 PM

FDA Approves Leqselvi for Severe Alopecia

The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral selective inhibitor of the Janus kinases JAK1 and JAK2. In trials, the three most common adverse events were headache, acne, and nasopharyngitis.The approval was

HealthDay 02 August at 04.03 PM

Semaglutide Products Being Sold Online Without Prescriptions

Semaglutide products are being sold online, with products likely unregistered or unlicensed, according to a research letter published online Aug. 2 in JAMA Network Open.Amir Reza Ashraf, Pharm.D., from the University of Pécs in Hungary, and colleagues conducted a risk assessment of semaglutide online sourcing. Websites advertising semagl

HealthDay 01 August at 04.02 PM

Pharmacist Prescribing Can Reduce Stroke Risk in A-Fib Patients

Community pharmacists can play an effective role in closing gaps in the delivery of stroke risk reduction therapy by prescribing appropriate oral anticoagulation therapy (OAC) for high-risk older individuals with atrial fibrillation (AF), according to a study published online July 24 in&nbsp;JAMA Network Open.Roopinder K. Sandhu, M.D.

HealthDay 01 August at 03.47 PM

COVID-19 Vaccination May Increase Risk for Urinary Tract Symptoms

COVID-19 vaccination seems to have some side effects on the lower urinary tract and overactive bladder in younger adults, according to a study published online June 24 in Frontiers in Medicine.Marta de-la-Plaza-San-Frutos, from Universidad Europea de Madrid in Spain, and colleagues examined potential side effects of COVID-19 vaccinatio

HealthDay 31 July at 03.53 PM

Cholesterol Absorption Inhibitors May Cut Risk for Liver Cancer

The use of cholesterol absorption inhibitors is associated with a reduced risk for liver cancer, according to a study published online July 29 in&nbsp;Cancer.Shahriar A. Zamani, Ph.D., from the National Cancer Institute at the National Institutes of Health in Rockville, Maryland, and colleagues examined the risk for liver cancer for

HealthDay 31 July at 03.35 PM

Methotrexate Beneficial for Reducing Pain, Stiffness in Knee Osteoarthritis

For patients with knee osteoarthritis (KOA), methotrexate added to usual medication is associated with a significant reduction in pain and improvement in stiffness and function at six months, according to a study published online July 30 in the Annals of Internal Medicine.Sarah R. Kingsbury, Ph.D., from the University of Leeds in the

HealthDay 30 July at 03.43 PM

Toxicities Rare After Two Weeks of CAR T-Cell Therapy Infusion

New-onset cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are rare beyond two weeks following infusion of CD19-directed chimeric antigen receptor T (CAR T)-cell therapies, according to a study published online July 23 in Blood Advances.Noting that the U.S. Food and Drug Administration

HealthDay 30 July at 03.37 PM

Study Looks at Opioid Dispensing Among Youths Undergoing Surgery

Overall, 16.2 percent of opioid-naive youths undergoing a surgical procedure filled an initial opioid prescription one to 14 days before surgery, according to a study published online July 5 in JAMA Network Open.Tori N. Sutherland, M.D., M.P.H., from the Children's Hospital of Philadelphia, and colleagues characterized changes in preop

HealthDay 30 July at 03.32 PM

Nasal Sprays, Behavioral Intervention Aid in Treatment of Respiratory Illness

Use of nasal sprays and a behavioral intervention promoting physical activity and stress management can reduce antibiotic use for respiratory illness, according to a study published online July 11 in The Lancet Respiratory Medicine.Paul Little, M.B.B.S., M.D., from the University of Southampton in the United Kingdom, and colleagues exa

HealthDay 30 July at 03.26 PM

Once-Daily TAS-303 Superior to Placebo for Stress Urinary Incontinence

Once-daily TAS-303 is superior to placebo for treatment of stress urinary incontinence (SUI) in women, according to a study published in the August issue of The Journal of Urology.Satoru Takahashi, M.D., Ph.D., from Nihon University School of Medicine in Tokyo, and colleagues conducted a double-blind phase 2 study involving women with

HealthDay 30 July at 09.57 AM

FDA Warns of Accidental Overdoses From Compounded Versions of Ozempic

People taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration warns.These ODs typically are due to miscommunications or miscalculations regarding dosage, the FDA added.“Dosing errors have res

HealthDay 29 July at 09.30 PM

Semaglutide Seems Beneficial for Comorbid T2DM, Tobacco Use Disorder

For patients with type 2 diabetes mellitus (T2DM) and tobacco use disorder (TUD), new use of semaglutide is associated with lower risk of TUD-related health care measures compared with other antidiabetes medications, according to a study published online July 30 in the Annals of Internal Medicine.William Wang, from the Case Western Rese

HealthDay 29 July at 03.30 PM

Long-Acting Early Viral Inhibition Described in Context of Long-Acting Injectable Cabotegravir

In a research letter published online July 24 in the New England Journal of Medicine, the authors describe long-acting early viral inhibition (LEVI) among patients with acute HIV infection in the context of long-acting injectable cabotegravir (CAB-LA) preexposure prophylaxis (PrEP). The research was published to coincide with the 25th Internat

HealthDay 29 July at 03.30 PM

Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia

For adult patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) who have measurable residual disease (MRD)-negative remission, blinatumomab in addition to consolidation chemotherapy is associated with improved overall survival, according to a study published in the July 25 issue of the New England Journal of Medicine.Mar

HealthDay 26 July at 03.50 PM

Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen Sclerosus

Hydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the&nbsp;International Journal of Dermatology.Christeebella O. Akpala, from the Mayo Clinic in Rochester, Minnesota, and colleagues analyzed the demog

HealthDay 26 July at 10.45 AM

Certain Abbott Blood Sugar Monitors May Give Incorrect Readings

Abbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings."Abbott has recently identified a small number of FreeStyle Libre 3 sensors that may provide incorrect high glucose readings, which if undetected may pose a potential health risk for people living

HealthDay 26 July at 10.12 AM

Fake Oxycontin Pills Widespread and Potentially Deadly: Report

The rate at which young Americans are ending up in hospital ICUs after using fake Oxycontin pills spiked with fentanyl is soaring, especially in the U.S. West, a new report warns.Medical toxicology data from one unnamed hospital in the western U.S. found the number of cases involving overdoses involving fake "M-30" Oxycontin pills rose from just

HealthDay 25 July at 06.45 PM

Declines Seen in Medical, Nonmedical Use of Prescription Meds Among Teens

U.S adolescents reported declines in medical use and nonmedical use (NMU) of prescription stimulants, opioids, and benzodiazepines from 2009 to 2022, according to a research letter published online July 24 in the Journal of the American Medical Association.Sean Esteban McCabe, Ph.D., from the University of Michigan School of Nursing i

HealthDay 25 July at 03.23 PM

Exposure to Hydroxyurea Does Not Impact Ovarian Reserve in Sickle Cell

For girls and young women with sickle cell disease (SCD), exposure to hydroxyurea does not reduce ovarian reserve, according to a study published online July 18 in Blood Advances.Tamara Diesch-Furlanetto, Ph.D., from the University of Basel Children's Hospital in Switzerland, and colleagues counted follicles and categorized them based

HealthDay 24 July at 03.24 PM

Lack of Institutional Support May Drive Physician Reluctance to Address Addiction

Lack of institutional support is the most common reason for physicians to have reluctance to address substance use and addiction in their clinical practices, according to a review published online July 17 in&nbsp;JAMA Network Open.Melinda Campopiano von Klimo, M.D., from JBS International Inc. in North Bethesda, Maryland, and colleag

HealthDay 24 July at 03.23 PM

Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for Eczema

Use of oral corticosteroids for &gt;90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July 19 in&nbsp;JAMA Network Open.Yong Hyun Jang, M.D., Ph.D., from Kyungpook National University in Daegu, South Korea, and colleagues examined the association betwee

HealthDay 23 July at 10.27 PM

Long-Term Sulfonylurea Use Tied to Impaired Awareness of Hypoglycemia

The prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of the&nbsp;Annals of Family Medicine.Hsiang-Ju Cheng, M.D., from the National Cheng Kung University in Tainan, Taiwan, and colleagues investigated the relationship bet

HealthDay 23 July at 03.50 PM

Digoxin, Beta-Blockers Have Equivalent Effects on Heart Rate in A-Fib

For patients with atrial fibrillation, digoxin and beta-blockers have equivalent effects on heart rate at rest and on exertion, according to a study published online July 15 in Nature Medicine.Simrat K. Gill, from the University of Birmingham in the United Kingdom, and colleagues compared heart rate in older, multimorbid patients with

HealthDay 23 July at 03.45 PM

Long COVID Incidence Declined Over Course of Pandemic

The cumulative incidence of postacute sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (PASC) during the first year after infection decreased over the course of the pandemic, according to a study published online July 17 in the&nbsp;New England Journal of Medicine.Yan Xie, Ph.D., from the Veterans Affa

HealthDay 22 July at 09.49 PM

2011 to 2023 Saw Increase in New GLP-1 Receptor Agonist Prescriptions

From 2011 to 2023, there was an increase in new glucagon like peptide 1 receptor agonist (GLP-1RA) prescriptions, according to a research letter published online July 23 in the Annals of Internal Medicine.Yee Hui Yeo, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined nationwide trends in GLP-1RA prescription

HealthDay 22 July at 09.48 PM

Study Looks at Co-Use of CYP2D6-Metabolizing Opioids, Antidepressants in Seniors

For older nursing home (NH) residents, use of CYP2D6-metabolized opioids concomitantly with CYP2D6-inhibiting antidepressants is associated with worsening pain and increased risk of opioid-related adverse events (ORAEs), according to a study published online July 23 in the Annals of Internal Medicine.Yu-Jung Jenny Wei, Ph.D., from the C

HealthDay 22 July at 03.15 PM

Neuromuscular Training Cuts Onset of Chemo-Induced Peripheral Neuropathy

Neuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online July 1 in JAMA Internal Medicine.Fiona Streckmann, Ph.D., from the University of Basel in Switzerland, and colleagues examined whether sensorimotor training (SMT) and whole-body vibration (WBV) training re

HealthDay 19 July at 04.13 PM

Efanesoctocog Alfa Prophylaxis Beneficial for Children With Hemophilia A

For children with severe hemophilia A, once-weekly prophylaxis with efanesoctocog alfa is associated with high sustained factor VIII activity, resulting in effective prevention of bleeding, according to a study published in the July 18 issue of the New England Journal of Medicine.Lynn Malec, M.D., from the Versiti Blood Research Institu

HealthDay 19 July at 03.54 PM

Micronutrient Supplementation Slows Geographic Atrophy Progression

Oral micronutrient supplementation slows geographic atrophy (GA) progression in age-related macular degeneration (AMD), according to a study published online July 16 in Ophthalmology.Tiarnan D.L. Keenan, B.M., B.Ch., Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined whether oral supplements slo

HealthDay 19 July at 03.51 PM

COVID-19 Infection, Vaccination Not Linked to Congenital Anomalies

COVID-19 infection and vaccination during the first trimester of pregnancy are not associated with congenital anomalies, according to a study published online July 17 in The BMJ.Maria C. Magnus, Ph.D., from the Norwegian Institute of Public Health in Oslo, and colleagues conducted a prospective cohort study of 343,066 live-born singleto

HealthDay 18 July at 04.04 PM

Postexposure Prophylaxis With Nirmatrelvir-Ritonavir Does Not Cut COVID-19 Infection

Postexposure prophylaxis with nirmatrelvir-ritonavir for five or 10 days does not reduce the risk for symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published in the July 18 issue of the New England Journal of Medicine.Jennifer Hammond, Ph.D., from Pfizer in Collegeville, Penns

HealthDay 17 July at 10.29 PM

Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease

For patients with moderate-to-severe Crohn disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a study published in the July 18 issue of the New England Journal of Medicine.Laurent Peyrin-Biroulet, M.D., Ph.D., from the INFINY Institut

HealthDay 17 July at 10.27 PM

Ofatumumab Effective for MS Across Racial, Ethnic Subgroups

For patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective than teriflunomide across racial and ethnic subgroups, according to a study published online July 17 in Neurology.Mitzi J. Williams, M.D., from the Joi Life Wellness MS Center in Atlanta, and colleagues conducted a post-hoc analysis to compare the prop

HealthDay 17 July at 03.29 PM

Extended-Release Oral Ketamine Effective for Treatment-Resistant Depression

For patients with treatment-resistant depression, racemic ketamine, given as an extended-release tablet (R-107), administered orally, is effective, safe, and well tolerated, according to a study published online June 24 in Nature Medicine.Paul Glue, M.D., from the University of Otago in Dunedin, New Zealand, and colleagues examined t

HealthDay 17 July at 03.14 PM

Aging Into Medicare Tied to Higher Drug Costs for People With Diabetes

As people with diabetes age into Medicare, they face increased quarterly out-of-pocket costs for medication, according to a study published online July 9 in&nbsp;JAMA Network Open.Douglas Barthold, Ph.D., from the University of Washington in Seattle, and colleagues examined whether reaching age 65 years is associated with changes in

HealthDay 16 July at 10.52 PM

Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With Migraine

For patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no inhibition (topiramate) or indirect inhibition (triptans), according to a research letter published online July 10 in JAMA Dermatology.Chris

HealthDay 16 July at 03.47 PM

Benzodiazepines Not Tied to Higher Dementia Risk in Older Adults

Use of benzodiazepines is not associated with increased dementia risk in older adults, according to a study published online July 2 in&nbsp;BMC Medicine.Ilse vom Hofe, from Erasmus University Medical Center in the Netherlands, and colleagues examined long-term effects of benzodiazepines (anxiolytics or sedative-hypnotics) on neurodegen

HealthDay 16 July at 03.40 PM

Self-Imposed Use Cessation Dates Tied to Ophthalmic Drop Waste

Self-imposed use cessation dates (SUCD) for multiuse eye drop bottles leads to significant drug waste and associated costs, according to a report published online July 1 in&nbsp;Ophthalmology.John M. Tan, from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues quantified the volume of drugs discarded in ambula

HealthDay 16 July at 03.29 PM

Suicidal Ideation, Behaviors Not Increased With GLP-1 RAs for Seniors With T2D

For older adults with type 2 diabetes (T2D), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is not associated with a significantly increased risk for suicidal ideation and behaviors, according to a study published online July 16 in the Annals of Internal Medicine.Huilin Tang, from the University of Florida College of Phar

HealthDay 15 July at 10.00 PM

Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia Risk

Compared with other antidiabetic classes, metformin and sodium glucose co-transporter-2 inhibitors (SGLT2is) exhibit significantly lower dementia risk, according to a review published online May 3 in the American Journal of Preventive Medicine.Yongjun Sunwoo, from the College of Pharmacy at Kyung Hee University in Seoul, South Korea, an

HealthDay 15 July at 03.23 PM

Low Quantity of Opioids Used After ED Discharge for Acute Pain

For patients presenting with acute pain, the quantity of opioids consumed during two weeks after emergency department discharge is low and varies across pain conditions, according to a study published online July 15 in CMAJ, the journal of the Canadian Medical Association.Raoul Daoust, M.D., from Sacré-Coeur Hospital in Montreal, and co

HealthDay 15 July at 12.36 PM

Global Childhood Vaccination Rates Still Haven't Recovered from Pandemic Declines

More than four years after the pandemic began, childhood vaccination rates worldwide have yet to recover, a new report shows.The latest data, issued Monday by the World Health Organization and the United Nations International Children’s Emergency Fund (UNICEF), underscore the need for continuing to try to catch-up to pre-pandemic levels.“

HealthDay 12 July at 10.23 PM

CDC Reports Seven Cases of Illness After Possible Counterfeit Botox Injections

Seven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Christine M. Thomas, D.O., from the CDC in Atlanta, and colleagues charact

HealthDay 12 July at 10.21 PM

More Women Than Men Experience Nonphysical Violence in Health Care Workforce

Women in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS Global Public Health.Sioban Nelson, R.N., Ph.D., from the University of Toronto, and colleagues conducted a scopin

HealthDay 12 July at 10.16 PM

Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years Later

Three of four patients stop taking semaglutide (Ozempic or Wegovy) two years after being prescribed the glucagon-like peptide-1 receptor agonist (GLP-1 RA) for weight loss, according to new analysis conducted by Prime Therapeutics and Magellan Rx Management (MRx).For the review, pharmacy and medical claims data for 3,364 people with insurance pl

HealthDay 12 July at 03.43 PM

More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use Disorder

Many people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28 in&nbsp;JAMA Network Open.Brandon del Pozo, Ph.D., from the Brown University School of Public Health in Providence, Rhode Island, and colleagues surveyed 1,234 individu

HealthDay 12 July at 03.38 PM

Prenatal Vaccination With RSV Prefusion F Does Not Increase Risk for Preterm Birth

Prenatal vaccination with a nonadjuvanted bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) protein subunit vaccine is not associated with an increased risk for preterm birth (PTB), according to a study published online July 8 in JAMA Network Open.In a retrospective observational cohort study, Moeun Son, M.D., from the We

HealthDay 11 July at 10.11 PM

FDA Approves Zoryve for Atopic Dermatitis

The U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).Zoryve is a once-daily, steroid-free cream that the company says will be available at the end of July.The approval was based on resu

HealthDay 11 July at 04.04 PM

GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D

For patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers (OACs) compared with insulin, according to a study published online July 5 in JAMA Network Open.Lindsey Wang, from Case Western Reserve University School of Medicine

HealthDay 11 July at 03.45 PM

First-Trimester COVID-19 Vaccine Does Not Increase Risk for Birth Defects

First-trimester mRNA COVID-19 vaccine exposure is not associated with an increased risk for selected major structural birth defects, according to a study published online July 1 in&nbsp;JAMA Pediatrics.Elyse O. Kharbanda, M.D., M.P.H., from HealthPartners Institute in Minneapolis, and colleagues assessed whether receipt of an mRNA COV

HealthDay 10 July at 10.23 PM

Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization

Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a study published in the July 11 issue of the New England Journal of Medicine.Zein Assad, M.D., from the Robert Debré University Hospital in Paris, and colleagues conduct

HealthDay 10 July at 03.58 PM

Study Looks at Impact of Incentivizing Smoking Cessation in Addition to Usual Care

Incentivizing smoking cessation increases smoking cessation through 12 weeks, but not at 26 weeks, when missing data are treated as smoking, according to a study published online July 2 in JAMA Network Open.Darla E. Kendzor, Ph.D., from the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues randomly assign

HealthDay 10 July at 03.12 PM

Most Children With Conjunctivitis Have Rx for Topical Antibiotics Filled

More than two-thirds of children with conjunctivitis have a prescription filled for topical antibiotics within one day of an ambulatory care visit, according to a research letter published online June 27 in JAMA Ophthalmology.Daniel J. Shapiro, M.D., M.P.H., from the University of California, San Francisco, and colleagues examined pr

HealthDay 09 July at 03.32 PM

1999 to Mid-2000s Saw Increase in Seniors Using Prescription Meds

From 1999 to the mid-2000s, the proportion of U.S. adults aged 65 years or older who used prescription medications increased, according to a research letter published online July 1 in JAMA Internal Medicine.Gabriel K. Innes, V.M.D., Ph.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and colleagues analyzed dat

HealthDay 09 July at 12.41 PM

More Americans Now Think Abortion Should Be Allowed in Any Circumstance

Two years after the U.S. Supreme Court overturned Roe v. Wade, more Americans think their state should allow a woman to get a legal abortion for any reason, a new poll finds.Just over 6 in 10 of those questioned say women should have that right, compared to just under 50% of Americans who held the same belief in 2021, the new <a href="https://ap

HealthDay 08 July at 09.38 PM

Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide

Tirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA Internal Medicine.Patricia J. Rodriguez, Ph.D., from Truveta Inc. in Bellevue, Washington, and colleagues compared on-treatment weight loss and rates of gastrointest

HealthDay 08 July at 09.36 PM

Acupuncture Can Reduce Methadone Dose, Opioid Craving

For individuals with opioid use disorder receiving methadone maintenance treatment (MMT), eight weeks of acupuncture is superior to sham acupuncture for reducing methadone dose and opioid craving, according to a study published online July 9 in the Annals of Internal Medicine.Liming Lu, M.D., from the Guangzhou University of Chinese Medi

HealthDay 08 July at 09.33 PM

Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib

For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, according to a study published online July 9 in the Annals of Internal Medicine.Tracey G. Simon, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and co

HealthDay 08 July at 03.26 PM

Tisotumab Vedotin Efficacious for Recurrent Cervical Cancer

Second- or third-line treatment with tisotumab vedotin is efficacious for patients with recurrent cervical cancer, according to a study published in the July 4 issue of the New England Journal of Medicine.Ignace Vergote, M.D., Ph.D., from Universitaire Ziekenhuizen Leuven in Belgium, and colleagues conducted a phase 3, multinational, ope

HealthDay 08 July at 03.17 PM

ACEi, ARB Use Linked to Lower Risk for Kidney Failure With Replacement Therapy

For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney failure with replacement therapy (KFRT) but not death, according to a study published online July 2 in the Annals of Internal Medicine.Elai

HealthDay 08 July at 02.56 PM

Study Looks at Abortion Rates With No-Test Telehealth Screening, Meds Mailing

Access to medication abortion using history-based (no-test) eligibility assessment, including through telehealth, and mailing of mifepristone lead to similar rates of complete abortion as in-person care with ultrasonography, according to a study published online June 24 in the Journal of the American Medical Association.Lauren J. Ralph,

HealthDay 08 July at 02.52 PM

Granting Waiver for Cancer Treatment Does Not Affect Safety, Efficacy Outcomes

In a trial involving patients with therapy-refractory cancer treated with approved targeted or immunotherapies, matched to their tumor molecular profile but outside their registered indications, those for whom a waiver was granted had similar serious adverse event rates and clinical benefit rates as those who did not receive a waiver, according to a stu

HealthDay 03 July at 08.32 PM

Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy

Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity, according to a study published online July 3 in JAMA Ophthalmology.Jimena Tatiana Hathaway, M.D., M.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and

HealthDay 03 July at 03.07 PM

Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma Symptoms

Higher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter published online July 3 in JAMA Network Open.Matthew M. Davis, M.D., from Nemours Children's Health in Wilmington, Delaware, and Lakshmi K. Halasyamani, M.D., from Endeavor Health in Eva

HealthDay 03 July at 02.50 PM

Many Teen Girls Seeking Care in the ED at High Risk for Pregnancy

Sexually active adolescents seeking care in the emergency department have a high risk for pregnancy, and the emergency department may provide a feasible environment to offer contraception counseling, according to a study published online June 28 in&nbsp;JAMA Network Open.Hannah Canter, M.D., from Oregon Health and Science University i

HealthDay 02 July at 07.33 PM

FDA Approves New Drug to Treat Alzheimer's

A new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday.In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the m

HealthDay 02 July at 05.05 PM

U.S. Government to Pay Moderna $176 Million to Develop mRNA Flu Vaccine

U.S. health officials announced Tuesday that the federal government will pay Moderna $176 million to speed development of a pandemic flu vaccine based on mRNA technology.Such a vaccine could be used to treat bird flu in people, as concern grows about&nbsp;H5N1 cases spreading in dairy cows&nbsp;across the country, the U.S. Department of Health a

HealthDay 02 July at 04.01 PM

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in&nbsp;JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass

HealthDay 01 July at 10.10 PM

Small Differences in Weight Change With First-Line Antidepressants

For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study published online July 2 in the Annals of Internal Medicine.Joshua Petimar, Sc.D., from Harvard Medical School and Harvard Pilgrim Health Care Institute in Boston, and colleagues conducted

HealthDay 01 July at 03.22 PM

Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer

For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line treatment, according to a study published online June 26 in the New England Journal of Medicine.Byoung C. Cho, M.D., Ph.D., from the Yonsei Cancer Ce

HealthDay 28 June at 10.09 PM

NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians

Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National Comprehensive Cancer Network survey.Following data published one year ago and six months ago illustrating shortages of crucial cancer drugs, the National Comprehensive Cancer Network published new results

HealthDay 28 June at 09.54 PM

Small Number of Procedures Account for Large Number of Opioid Prescriptions

A small number of surgical procedures, including orthopedic procedures and cesarean delivery, account for a large proportion of opioid prescriptions dispensed after surgery, according to a study published online June 26 in JAMA Network Open.Dominic Alessio-Bilowus, from Michigan Medicine in Ann Arbor, and colleagues examined the surgica

HealthDay 28 June at 03.02 PM

Clinical Response Seen for Patients With Severe Asthma Initiating Biologics

Patients with severe asthma initiating biologics exhibit clinical responses and super-responses, but 40 to 50 percent do not meet response criteria, according to a study published online June 22 in Allergy.Eve Denton, M.B.B.S., from Alfred Health in Melbourne, Australia, and colleagues examined responsiveness to biologics in a real-worl

HealthDay 28 June at 03.01 PM

Guidelines Address RT for Management of HPV-Linked Oropharyngeal Cancer

In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in Practical Radiation Oncology, recommendations are presented for the use of radiation therapy (RT) for management of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC).Danielle N. Margali

HealthDay 28 June at 02.12 PM

Supreme Court Rejects Purdue Pharma Opioid Settlement

The U.S. Supreme Court on Thursday struck down a controversial settlement that drug maker Purdue Pharma had reached with victims of the opioid epidemic.The ruling threatens a massive bankruptcy plan that would have protected the Sackler family, which controls the compan

HealthDay 28 June at 11.51 AM

CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of Age

As a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one of the updated COVID vaccines when they become available this fall.The recommendation was issued Thurs

HealthDay 27 June at 09.36 PM

Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them

Only one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according to research published in the June 27 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Deborah Dowell, M.D., from the CDC in Atlanta, and colleagues characterized U.

HealthDay 27 June at 03.19 PM

Immunoglobulin Replacement Therapy Beneficial for Blood Cancers

Immunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum

HealthDay 27 June at 03.18 PM

Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD

For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health, according to a study published online June 25 in JAMA Network Open.Simon Birk Kjær Jensen, Ph.D., from the University of Copenhagen in Denm

HealthDay 27 June at 03.16 PM

ADA: Inhaled Insulin Shows Promise for Adults With Type 1 Diabetes

Inhaled insulin is associated with improved hemoglobin A1c (HbA1c) levels over 16 weeks among adults with type 1 diabetes when compared to usual care, according to a study presented at the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.Irl B. Hirsch, M.D., from the University of Washington in S

HealthDay 27 June at 03.14 PM

Dupilumab Ups Histologic Response for Pediatric Eosinophilic Esophagitis

For children with eosinophilic esophagitis, dupilumab results in a significantly higher percentage of histologic remission, according to a study published in the June 27 issue of the New England Journal of Medicine.Mirna Chehade, M.D., M.P.H., from Icahn School of Medicine at Mount Sinai in New York City, and colleagues randomly assig

HealthDay 27 June at 03.13 PM

PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon Cancer

PIK3CA mutational status may be beneficial for predicting response to addition of the cyclooxygenase 2 (COX-2) inhibitor celecoxib to standard adjuvant chemotherapy in stage III resected colon cancer, according to a study published online June 18 in the Journal of Clinical Oncology.Jonathan A. Nowak, M.D., Ph.D., from Brigham

HealthDay 27 June at 11.32 AM

CDC Strengthens RSV Vaccine Advice for Those Over 75

In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives.However, those a bit younger -- ages 60 to 74 -- should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung or heart disease, or if

HealthDay 26 June at 09.35 PM

Atogepant Efficacious for Patients With Chronic Migraine

For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27 in Neurology.Peter J. Goadsby, M.D., Ph.D., from King's College London, and colleagues examined the efficacy of atogepant for the preventive treatment of CM in participants with and wit

HealthDay 26 June at 09.32 PM

Histologic Response Up With Benralizumab for Eosinophilic Esophagitis

Benralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not affect dysphagia symptoms, according to a study published in the June 27 issue of the New England Journal of Medicine.Marc E. Rothenberg, M.D., Ph.D., from the Leiden University Medical Center in the Netherlands, an

HealthDay 26 June at 07.46 PM

Multivitamin Use Not Linked to Mortality Benefit in U.S. Adults

Multivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online June 26 in JAMA Network Open.Erikka Loftfield, Ph.D., M.P.H., from the National Institutes of Health in Rockville, Maryland, and colleagues estimated the association of MV use with mortality risk, accounting for con

HealthDay 26 June at 06.03 PM

Glofitamab + GemOx Superior to Rituximab + GemOx for Lymphoma

Glofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) is superior to rituximab (R)-GemOx for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), according to a study presented at the annual hybrid congress of the European Hematology Association, held from June 13 to 16 in Madrid.Jeremy Abramson, M.D., from the Massachusett

HealthDay 26 June at 04.53 PM

Decrease in Oral Contraceptive Fills Seen After Dobbs Ruling

The Dobbs v Jackson Women's Health Organization decision, allowing states to strengthen restrictions on abortion access, was associated with declines in prescription fills for oral contraceptives, according to a study published online June 26 in JAMA Network Open.Dima M. Qato, Pharm.D., M.P.H., Ph.D., from the University of

HealthDay 26 June at 04.05 PM

Pediatric Surgical Opioid Prescribing Concentrated Among a Few Procedures

Pediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a study published online June 26 in Pediatrics.Kao-Ping Chua, M.D., Ph.D., from the Institute for Healthcare Policy and Innovation in Ann Arbor, Michigan, and colleagues conducted a cross-

HealthDay 26 June at 03.26 PM

ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure

For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar improvements in heart failure-related symptoms in men and women, according to a study published online June 23 in the Journal of the American College of Cardiology to coinc

HealthDay 26 June at 03.26 PM

ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA

Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online June 21 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.At

HealthDay 25 June at 09.42 PM

Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus

For patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA Dermatology.Shawn G. Kwatra, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examine

HealthDay 25 June at 03.06 PM

COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes

mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the June issue of&nbsp;Obstetrics &amp; Gynecology.Kimberly K. Vesco, M.D., M.P.H., from Kaiser Permanente Center for Health Research in Portland, Oregon, and colleagues evaluated the asso

HealthDay 25 June at 03.04 PM

ADHD Meds May Help Control Opioid Use Disorder in Pregnancy

Psychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in&nbsp;Nature Mental Health.Kevin Y. Xu, M.D.,&nbsp;M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues used U.S. multistate administrative data to examine the risks and benef

HealthDay 25 June at 03.03 PM

Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder

Semaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in&nbsp;Nature Communications.William Wang, from Case Western Reserve University in Cleveland, and colleagues used electronic health records of 83,825 patients with obesity to examine associa

HealthDay 25 June at 03.00 PM

SNP rs13194504 AA Genotype Linked to Severity of Tardive Dyskinesia

For patients with schizophrenia, the single-nucleotide polymorphism (SNP) rs13194504 AA genotype is associated with reduced severity of tardive dyskinesia (TD), but is not associated with occurrence, according to a study recently published in Human Psychopharmacology: Clinical &amp; Experimental.Ruoyu Wang, from the Centre for Addictio

HealthDay 25 June at 12.15 PM

Summer COVID Cases Are Rising Across America

As scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday.In evidence that suggests a COVID summer wave is underway, case counts are most likely&nbsp;increasing in 39 states&nbsp;and aren’t declining anywhere in the c

HealthDay 24 June at 09.25 PM

Medically Advised Aspirin Use Lower in 2021 Than 2012 to 2017

Medically advised aspirin use was lower in 2021 than in 2012 to 2017 among older adults, according to a research letter published online June 25 in the Annals of Internal Medicine.Mohak Gupta, M.D., from the Cleveland Clinic, and colleagues characterized trends in prevalence of aspirin use for CVD prevention among U.S. adults aged 40 ye

HealthDay 24 June at 09.20 PM

FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy

The U.S. Food and Drug Administration has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in individuals ≥4 years with DMD with a confirmed mutation in the DMD gene.Elevidys is a single-dose, intravenous recombinant gene therapy designed to prod

HealthDay 24 June at 03.23 PM

U.S. Supreme Court Agrees to Hear Case on Medical Care for Transgender Youth

The U.S. Supreme Court announced Monday that it would hear a case on a Tennessee law that bans transgender minors from receiving certain medical treatments in that state.The banned treatments include puberty-blocking drugs or hormonal therapies.It's the

HealthDay 24 June at 03.02 PM

Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma

For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published online June 19 in the New England Journal of Medicine.Georgina V. Long, M.D., Ph.D., from the University of Sydney, and colleagues random

HealthDay 24 June at 11.44 AM

Twice-a-Year Injection Gives Women Full Protection Against HIV, Trial Finds

Just two injections a year of a new HIV drug protected young women in Africa from infection with the sexually transmitted disease, new trial results show.In announcing the findings, Gilead Sciences Inc. said its HIV medication lenacapavir demonstrated 100% efficacy as a prev

HealthDay 21 June at 10.54 PM

FDA Approves KEYTRUDA + Chemo for Primary Advanced, Recurrent Endometrial Carcinoma

The U.S. Food and Drug Administration has approved Keytruda (pembrolizumab) plus chemotherapy as treatment for adult patients with primary advanced or recurrent endometrial carcinoma. This is the third FDA-approved indication for Keytruda in endometrial carcinoma.The approval is for Keytruda, an anti-programmed death receptor-1&nbsp;(anti-PD-1)

HealthDay 21 June at 10.51 PM

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.Capvaxive is specifically designed to help protect adults against the serotypes that cause the majority of invasive pneumococcal&nbsp;disease cases, inc

HealthDay 21 June at 03.36 PM

Timing of Metformin Important in Metformin-Treated Type 2 Diabetes

Glucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study recently published in Diabetologia.Cong Xie, Ph.D., from the University of Adelaide in Australia, and colleagues studied 16 participants with type 2 diabetes that was re

HealthDay 21 June at 03.23 PM

Improved Outcomes Seen With Ibrutinib in Chronic Lymphocytic Leukemia

First-line ibrutinib is associated with better outcomes than chemoimmunotherapy among patients with chronic lymphocytic leukemia (CLL), according to a study published online May 13 in Clinical Lymphoma, Myeloma &amp; Leukemia.Nilanjan Ghosh, M.D., Ph.D., from the Levine Cancer Institute in Charlotte, North Carolina, and colleagues condu

HealthDay 21 June at 03.20 PM

Angiotensin Receptor Blocker Use Linked to Lower Incidence of Epilepsy

For patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy compared with other antihypertensive medications, according to a study published online June 17 in JAMA Neurology.Xuerong Wen, Ph.D., from the University of Rhode Island in Kingston, and colleagues conducted a retrosp

HealthDay 21 June at 03.06 PM

Fewer Adults Eligible for Statins With PREVENT Equations

Use of the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations reduces the number of adults meeting criteria for primary prevention statin therapy compared with use of the 2013 pooled cohort equations (PCEs), according to a study published online June 10 in JAMA Internal Medicine.Timothy S. Anderson, M.D., from the Univ

HealthDay 21 June at 11.43 AM

WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs

Both the World Health Organization and Eli Lilly warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.The WHO warning said that the inter

HealthDay 20 June at 08.47 PM

FDA Approves Augtyro for NTRK-Positive Advanced Solid Tumors

The U.S. Food and Drug Administration has approved Augtyro (repotrectinib), a next-generation tyrosine kinase inhibitor (TKI), for the treatment of patients with neurotrophic tyrosine receptor kinase (NTRK)-positive locally advanced or metastatic solid tumors.Augtyro is approved for adult and pediatric patients (aged 12 years and olde

HealthDay 20 June at 04.00 PM

ViPOR Results in Durable Remission in Specific Subtypes of Lymphoma

For patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) yields durable remission, according to a study published in the June 20 issue of the New England Journal of Medicine.Christopher Melani, M.D., fro

HealthDay 20 June at 03.52 PM

About One-Third of Mental Health Facilities Offer Meds for Opioid Addiction

About one-third of community outpatient mental health treatment facilities (MHTFs) offer medications for opioid use disorder (MOUD), according to a study published online June 18 in JAMA Network Open.Jonathan Cantor, Ph.D., from RAND in Santa Monica, California, and colleagues quantified the availability of MOUD at community outpatien

HealthDay 20 June at 03.34 PM

Reteplase Superior to Alteplase Within 4.5 Hours of Ischemic Stroke

Reteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to a study published online June 14 in the New England Journal of Medicine to coincide with the 10th Annual Conference of the Chinese Stroke Association &amp; Tiantan International Stroke Conference 2024, held from June 14

HealthDay 19 June at 09.29 PM

Dementia With Lewy Bodies Risk Down With α-1 Adrenergic Receptor Antagonists

Men taking α-1 adrenergic receptor antagonists terazosin, doxazosin, and alfuzosin (Tz/Dz/Az) seem to have a lower risk for dementia with Lewy bodies (DLB), according to a study published online June 19 in Neurology.Alexander Hart, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues used a new-user active compa

HealthDay 19 June at 03.55 PM

Low-Dose Direct Oral Anticoagulants Tied to More Bleeding Episodes

Patients with atrial fibrillation (AF) on low doses of direct oral anticoagulants (DOACs) have more bleeding episodes than those on standard doses, according to a study published online June 6 in&nbsp;Blood Advances.Gualtiero Palareti, M.D., from Fondazione Arianna Anticoagulazione in Bologna, Italy, and colleagues collected venous b

HealthDay 19 June at 03.52 PM

Varenicline, Nicotine-Containing E-Cigarettes Help in Quitting Smoking

Varenicline and nicotine-containing electronic cigarettes (ECs) are both effective in helping individuals in quitting smoking conventional cigarettes, according to a study published online June 17 in&nbsp;JAMA Internal Medicine.Anna Tuisku, Ph.D., from Lapland Central Hospital in Finland, and colleagues randomly assigned 458 particip

HealthDay 19 June at 03.48 PM

Nearly One in Four Do Not Recover From COVID-19 by 90 Days

Just under one-quarter of adults with self-reported COVID-19 report they had not recovered by 90 days, according to a study published online June 17 in&nbsp;JAMA Network Open.Elizabeth C. Oelsner, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues used data from 14 ongoing National Institutes of

HealthDay 18 June at 09.11 PM

Approximately 7 Percent of U.S. Population Uninsured in 2023

In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from

HealthDay 18 June at 03.49 PM

Trametinib Safe, Effective for Juvenile Myelomonocytic Leukemia

For children with relapsed or refractory juvenile myelomonocytic leukemia (JMML), trametinib is safe and effective, according to a study published online June 12 in Cancer Discovery.Noting that patients with relapsed or refractory (advanced) JMML have poor outcomes, Elliot Stieglitz, M.D., from the University of California San Francisc

HealthDay 18 June at 03.46 PM

Multimodal Antiobesity Medications Yield Superior Preoperative Weight Loss

Combining antiobesity medications enhances preoperative weight loss in individuals with high body mass index (BMI) preparing for metabolic surgery, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.Michael Kachmar, D.O., from the Pennington Biome

HealthDay 18 June at 03.44 PM

Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect

Lebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago.Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the George Washington Unive

HealthDay 18 June at 03.32 PM

Continuing Metformin in Pregnancy Has Little Effect on Nonlive Birth

Continuing metformin and adding insulin in early pregnancy does not significantly alter the risk for nonlive birth or live birth with congenital malformations compared with switching to insulin monotherapy, according to a study published online June 18 in the Annals of Internal Medicine.Yu-Han Chiu, M.D., Sc.D., from the Harvard T.H. C

HealthDay 18 June at 09.50 AM

Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to Expire

In a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h

HealthDay 17 June at 10.55 PM

Paternal Metformin Use Not Linked to Major Congenital Malformations

Paternal use of metformin in monotherapy is not associated with an increased risk for major congenital malformations (MCMs), according to a study published online June 18 in the Annals of Internal Medicine.Ran S. Rotem, Sc.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined the association between p

HealthDay 17 June at 04.12 PM

2008 to 2021 Saw Increase in Prevalence of Chronic HTN in Pregnancy

For pregnant individuals, the prevalence of chronic hypertension more than doubled between 2008 and 2021, according to a study published online June 17 in Hypertension.Stephanie A. Leonard, Ph.D., from the Stanford University School of Medicine in California, and colleagues analyzed commercial insurance claims from 2007 to 2021 and asse

HealthDay 17 June at 04.09 PM

Few Receive Meds for Opioid Use Disorder After Nonfatal Overdose

In the 12 months after a nonfatal overdose, few Medicare beneficiaries receive medications for opioid use disorder (MOUD) or fill a naloxone prescription, according to a study published online June 17 in JAMA Internal Medicine.Christopher M. Jones, Pharm.D., Dr.P.H., from the Substance Abuse and Mental Health Services Administration in

HealthDay 17 June at 03.58 PM

Survodutide Tied to Significant Improvement in Fatty Liver Disease

Most patients taking survodutide, a dual agonist of glucagon receptor and glucagon-like peptide-1 (GLP-1) receptor, experience significant improvement in metabolic dysfunction-associated steatohepatitis (MASH) without worsening of fibrosis, according to a phase 2 study published online June 7 in the&nbsp;New England Journal of Medicine&nbsp;to

HealthDay 17 June at 03.55 PM

Pantoprazole Cuts GI Bleeding in Patients Undergoing Invasive Ventilation

Pantoprazole results in a significantly lower risk for clinically important upper gastrointestinal bleeding than placebo, with no increase in mortality, among patients undergoing invasive ventilation, according to a study published online June 14 in the New England Journal of Medicine to coincide with the annual Critical Care Reviews Meeting,

HealthDay 14 June at 08.51 PM

FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy

The U.S. Food and Drug Administration has approved the first generic version of Emflaza (deflazacort) oral suspension for Duchenne muscular dystrophy (DMD).Deflazacort oral suspension is a corticosteroid indicated to treat DMD in patients 5 years of age and older but is contraindicated in patients with known hypersensitivity to deflazacort. The

HealthDay 14 June at 03.35 PM

Prolonged β-Lactam Antibiotic Infusions Aid Sepsis, Septic Shock Outcomes

Among adults in the intensive care unit with sepsis or septic shock, the use of prolonged β-lactam antibiotic infusions is associated with lower risk of 90-day mortality compared with intermittent infusions, according to research published online June 12 in the&nbsp;Journal of the American Medical Association&nbsp;to coincide with the annual C

HealthDay 14 June at 03.32 PM

No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab

There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in the Annals of Allergy, Asthma &amp; Immunology.Noting that dupilumab targets the interleukin (IL)-4 receptor alpha sub

HealthDay 14 June at 12.05 PM

ADHD Patients Could Face Disrupted Access to Meds Following Fraud Case

The two top officers of a telehealth company that began to distribute ADHD drugs widely during the pandemic have been charged with health care fraud, the U.S. Department of Justice announced Thursday.The arrests will likely worsen ongoing shortages of&nbsp;Adderall&nbsp;and another ADHD medication,&nbsp;Vyvanse, experts said.“There are a

HealthDay 14 June at 10.50 AM

FDA Tells Vaccine Makers to Target New COVID Variant for Fall

COVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the U.S. Food and Drug Administration announced Thursday.It's a turnaround for the agency: The <a href="https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beg

HealthDay 13 June at 10.58 PM

Health Care Spending Growth Projected to Outpace GDP to 2032

Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare &amp; Medicaid Services in Baltimore, and colleagues projected growth in national health expend

HealthDay 13 June at 04.10 PM

GLP-1 RA Use Linked to Lower Quality of Bowel Preparation

The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published online in the June issue of the American Journal of Gastroenterology.Rebecca Yao, M.D., M.P.H., from the Mayo Clinic in R

HealthDay 13 June at 03.54 PM

Alternative Pembrolizumab Administration Yields Environmental Advantages

Alternative pembrolizumab administration strategies may have environmental advantages, such as less carbon dioxide emission, according to a study published in the June issue of The Lancet Oncology.Alex K. Bryant, M.D., from the Veterans Affairs Center for Clinical Management Research in Ann Arbor, Michigan, and colleagues conducted a

HealthDay 13 June at 03.46 PM

Tirzepatide Beneficial for Resolution of MASH in Patients With MASH, Fibrosis

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-severe fibrosis, 52 weeks of tirzepatide is more effective than placebo for resolution of MASH, according to a study published online June 8 in the New England Journal of Medicine to coincide with the annual congress of the European Association for the

HealthDay 13 June at 03.30 PM

Supreme Court Rejects Case That Would Have Curbed Access to Abortion Drug

The U.S. Supreme Court on Thursday threw out a case that aimed to curb access to the controversial abortion drug mifepristone, saying the plaintiffs who brought the case to the court had no legal standing to do so.In a unanimous vote, the nine judges <a href="https://www.supremecourt.gov/op

HealthDay 13 June at 11.17 AM

J&J Settles Talcum Powder Lawsuits From States for $700 Million

Johnson &amp; Johnson will pay $700 million to settle claims from 42 states and the District of Columbia that the company continued to market its talcum powder products even as evidence tied them to a heightened risk for cancer.J&amp;J did not admit to any wrongdoing in settling with the states, which were led by Florida, Texas and North Carol

HealthDay 12 June at 02.55 PM

Patients Can Take GLP-1 RA Medications Before Surgery

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications do slow gastric emptying but not by enough to warrant discontinuing medications before surgery, according to a review published in the June issue of the&nbsp;American Journal of Gastroenterology.Brent Hiramoto, M.D., from Brigham and Women's Hospital in Boston, and colle

HealthDay 12 June at 02.52 PM

ENDO: Novel Male Contraceptive Gel May Achieve Faster Sperm Suppression

A novel male contraceptive gel suppresses sperm production faster than other hormone-based methods for male birth control, according to a phase 2 study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Danielle Gross, from the Eunice Kennedy Shriver National Institute of Child Health and Human Developme

HealthDay 11 June at 03.58 PM

Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB Response

Short-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting neutralizing antibody (nAB) responses, according to a study published online June 11 in the Annals of Internal Medicine.Ethan G. Dutcher, M.D., Ph.D., from the University of California, San F

HealthDay 11 June at 03.54 PM

Melatonin Use Linked to Reduced Risk for Development, Progression of AMD

Melatonin use is associated with a reduced risk for development and progression of age-related macular degeneration (AMD), according to a study published online June 6 in JAMA Ophthalmology.Hejin Jeong, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted a retrospective cohort study to exa

HealthDay 11 June at 03.48 PM

No Link Seen Between Exposure to Immunosuppressive Therapy, Cancer in IBD Patients

There is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a history of cancer, according to a study published online May 18 in Clinical Gastroenterology and Hepatology.Steven H. Itzkowitz, M.D., from the Icahn School o

HealthDay 11 June at 03.45 PM

ENDO: Teprotumumab Shows Long-Term Efficacy for Thyroid Eye Disease

Most patients with thyroid eye disease treated with teprotumumab do not require additional treatments nearly two years later, according to a study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston, and simultaneously published online June 2 in&nbsp;Thyroid.George J. Kahaly, M.D., Ph.D., from the

HealthDay 11 June at 12.58 PM

FDA Advisors Support New Alzheimer's Drug

A U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer's outweigh its harms, which can include brain swelling and bleeding.Eli Lilly's donanemab did slow declines in thinking skills in patients with early-stage Alzheimer's: <a href="https://www.fda.gov/media/1791

HealthDay 10 June at 03.28 PM

Greater Reduction Seen in Mortality With Bariatric Surgery Than GLP-1 RAs

Bariatric metabolic surgery (BMS) is associated with a greater reduction in mortality than glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment among adults with a diabetes duration of 10 years or less, according to a study published online June 7 in JAMA Network Open.Dror Dicker, M.D., from Rabin Medical Center in Petah Tikva,

HealthDay 10 June at 03.22 PM

Vitamin D Suggested for Children, Seniors, Those With High-Risk Prediabetes

Empiric vitamin D supplementation is suggested for those aged 1 to 18 years, those older than 75 years, those who are pregnant, and those with high-risk prediabetes, according to an Endocrine Society clinical practice guideline published online June 3 in the Journal of Clinical Endocrinology &amp; Metabolism.Marie B. Demay, M.D., from M

HealthDay 10 June at 03.10 PM

New Clinical Score Can Predict Immune Checkpoint Blockade Response

For patients with cancer, a novel clinical score using a six-feature regression model can predict immune checkpoint blockade (ICB) response probability and patient survival, according to a study published online June 3 in Nature Cancer.Tian-Gen Chang, Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues an

HealthDay 10 June at 03.07 PM

Nirmatrelvir-Ritonavir No Aid for Long COVID Symptoms

A 15-day course of nirmatrelvir-ritonavir (NMV/r) is safe but does not demonstrate a significant benefit for improving postacute sequelae of SARS-CoV-2 infection (PASC) symptoms, according to a study published online June 7 in&nbsp;JAMA Internal Medicine to coincide with the Demystifying Long COVID North American Conference 2024, held from Jun

HealthDay 10 June at 03.03 PM

Bulevirtide + Peginterferon Alfa-2a Best Treatment for Chronic Hepatitis D

The combination of bulevirtide plus peginterferon alfa-2a is superior to bulevirtide monotherapy for achieving undetectable hepatitis D virus (HDV) RNA level at 24 weeks after the end of treatment in patients with chronic hepatitis D, according to a study published online June 6 in the&nbsp;New England Journal of Medicine to coincide with the

HealthDay 10 June at 01.02 PM

FDA Gives Nod to RSV Vaccine for People in Their 50s

The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.Drugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved

HealthDay 10 June at 12.22 PM

Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine

An experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday.The shot — for now called mRNA-1083 — "has met its primary endpoints, eliciting a higher immune response than the licensed comparator vaccines used in the trial," Mo

HealthDay 07 June at 03.34 PM

ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral Neuropathy

Germline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel (every three weeks) for early-stage breast cancer, according to a study published online June 3 in the Journal of Clinical Oncology to coincide with the annual meeting of the American Society

HealthDay 07 June at 03.34 PM

ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease

For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are associated with reduced risk of cardiovascular (CV) events compared with dipeptidyl peptidase 4 inhibitors (DPP-4i), according to a st

HealthDay 07 June at 03.33 PM

Isotretinoin Effective for Acne in Those Receiving Gender-Affirming Therapy

Isotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen

HealthDay 07 June at 03.32 PM

Mortality in Rheumatic Heart Disease Is High

Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June 5 in the&nbsp;Journal of the American Medical Association.Ganesan Karthikeyan, D.M., from the All India Institute of Medical Sciences in New Delhi, and colleagues assessed the risk an

HealthDay 06 June at 04.24 PM

Several Drugs Linked to Risk for Aneurysmal Subarachnoid Hemorrhage

Several commonly prescribed drugs are associated with aneurysmal subarachnoid hemorrhage (aSAH), according to a study published online June 5 in Neurology.Jos P. Kanning, from the University Medical Center Utrecht in the Netherlands, and colleagues conducted a drug-wide association study to examine the association between commonly pres

HealthDay 06 June at 04.20 PM

Many Patients Have Discontinuation Symptoms After Stopping Antidepressants

A considerable proportion of patients have discontinuation symptoms (e.g.,&nbsp;dizziness, headache, nausea, insomnia, and irritability) after discontinuing antidepressants, according to a review published online June 5 in The Lancet Psychiatry.Jonathan Henssler, M.D., from the University of Cologne in Germany, and colleagues conducted

HealthDay 06 June at 04.12 PM

ASCO: Ivonescimab Improves Progression-Free Survival in EGFR+ Lung Cancer

For patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR) variant, ivonescimab plus chemotherapy improves progression-free survival, according to a study published online May 31 in the Journal of the American Medical Association to coincide with the annual meeting of the American Society of Clinica

HealthDay 06 June at 12.19 PM

FDA Panel OKs New COVID Vaccine for Fall

A U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will encourage Americans to get the latest shots.The unanimous vote recommends that vaccine makers tailor the next vaccine to target the JN.1 variant, which&nbsp;dominated&nbsp;infections in the Unite

HealthDay 05 June at 09.18 PM

Neoadjuvant Nivolumab, Ipilimumab Safe for dMMR Colon Cancer

Neoadjuvant nivolumab plus ipilimumab has an acceptable safety profile in patients with locally advanced mismatch repair-deficient (dMMR) colon cancer, according to a study published in the June 6 issue of the New England Journal of Medicine.Myriam Chalabi, M.D., Ph.D., from the Netherlands Cancer Institute in Amsterdam, and colleague

HealthDay 05 June at 09.15 PM

CDC Recommends Doxycycline PEP for Gay Men, Transgender Women

In clinical guidelines issued by the U.S. Centers for Disease Control and Prevention and published June 4 in the agency's Morbidity and Mortality Weekly Report, recommendations are presented for the use of doxycycline postexposure prophylaxis (doxy PEP) for preventing sexually transmitted infections (STIs) in gay, bisexual, and other men who

HealthDay 05 June at 03.31 PM

ASCO: Osimertinib Improves Progression-Free Survival in EGFR-Mutated Lung Cancer

For patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC), treatment with osimertinib results in significantly longer progression-free survival, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Society of Clinical On

HealthDay 05 June at 03.28 PM

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable, macroscopic stage III melanoma, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Soc

HealthDay 05 June at 03.26 PM

ASCO: Asciminib Has Superior Efficacy to TKIs for Newly Diagnosed Leukemia

For patients with newly diagnosed chronic myeloid leukemia (CML), asciminib shows superior efficacy and a favorable safety profile compared with investigator-selected tyrosine kinase inhibitors (TKIs), according to a study published online May 31 in the New England Journal of Medicine to coincide with the annual meeting of the American Socie

HealthDay 05 June at 03.23 PM

ENDO: Crinecerfont Aids Patients With Congenital Adrenal Hyperplasia

Crinecerfont results in a greater decrease from baseline in the mean daily glucocorticoid dose among patients with congenital adrenal hyperplasia (CAH), according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Richa

HealthDay 05 June at 12.45 PM

FDA Panel Says No to MDMA as Treatment for PTSD

A U.S. Food and Drug Administration advisory panel on Tuesday voted against recommending the psychedelic MDMA for the treatment of post-traumatic stress disorder (PTSD).In a 10-1 vote, the panel determined the evidence amassed so far fails to show the controversial drug's benefits outweigh its risks, the Associated Press reported.

HealthDay 03 June at 09.00 PM

FDA Approves First Liquid, Nonstimulant ADHD Treatment

The U.S. Food and Drug Administration has approved once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).The once-a-day, extended-release, oral suspension treatment is a centrally acting alpha2-adrenergic agonist. It has nighttime dosing for the treatment of A

HealthDay 03 June at 03.59 PM

On-Demand Sebetralstat Speeds Symptom Relief in Hereditary Angioedema

For patients with type 1 or type 2 hereditary angioedema, sebetralstat provides faster times to beginning of symptom relief than placebo, according to a study published online May 31 in the New England Journal of Medicine to coincide with the annual congress of the European Academy of Allergy and Clinical Immunology, held from May 31 to June 3

HealthDay 03 June at 03.56 PM

Donidalorsen Cuts Attack Rate in Hereditary Angioedema

For patients with hereditary angioedema, donidalorsen reduces the attack rate, according to a study published online May 31 in the New England Journal of Medicine to coincide with the annual congress of the European Academy of Allergy and Clinical Immunology, held from May 31 to June 3 in Valencia, Spain.Marc A. Riedl, M.D., from the Uni

HealthDay 03 June at 03.53 PM

Plozasiran Reduces Triglyceride Levels in Mixed Hyperlipidemia

For individuals with mixed hyperlipidemia, plozasiran reduces triglyceride levels at 24 weeks, according to a study published online May 28 in the New England Journal of Medicine.Christie M. Ballantyne, M.D., from the Baylor College of Medicine and Texas Heart Institute in Houston, and colleagues conducted a 48-week, randomized trial ass

HealthDay 03 June at 03.47 PM

No Decline in Cardiovascular Events Seen With COVID-19 Vaccine After Acute Coronary Syndromes

Patients who have received at least one COVID-19 vaccine dose after acute coronary syndromes do not have a reduced risk for cardiovascular events, according to a research letter published online May 30 in JAMA Network Open.Henrique Andrade R. Fonseca, Ph.D., from Hospital Israelita Albert Einstein in São Paulo, Brazil, and colleagues con

HealthDay 03 June at 12.25 PM

U.S. Will Make Millions of Bird Flu Vaccines This Summer

As the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million doses of flu vaccine are now being prepared for possible use in humans.Since the outbreak in livestock began this spring, bird flu has been confirmed in three humans who worked on dairy farms in Texas and Michigan, and health experts are concerned th

HealthDay 31 May at 08.47 PM

Racial Disparity Seen in Naloxone Administration

In Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic people, according to a study published online May 29 in&nbsp;Addiction.Erin Takemoto, Ph.D., M.P.H., from the Pennsylvania Department of Health in Harrisburg, and colleagues characteriz

HealthDay 31 May at 03.51 PM

Teens May Experience Delays in Bipolar Progression After Major Depressive Disorder

Adolescents may experience delayed bipolar disorder (BD) progression after major depressive disorder (MDD) diagnosis, according to a study published online May 29 in&nbsp;JAMA Psychiatry.Adrian E. Desai Boström, M.D., Ph.D., from the Karolinska Institute in Stockholm, and colleagues examined the association of age at MDD onset with early

HealthDay 31 May at 03.43 PM

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from cardiovascular causes, according to a study published online May 24 in the New England Journal of Medicine to coincide with the annual European Renal Association Congress, held from May 23 to 26 in S

HealthDay 30 May at 04.04 PM

Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa

Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.Alexa B. Kimball, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues examined the efficacy and safety of b

HealthDay 30 May at 03.55 PM

Inappropriate Antibiotic Prescribing Identified in Safety-Net Populations

Inappropriate antibiotic prescribing is common with or without a plausible antibiotic indication, and inappropriate prescribing is also common in U.S. emergency department visits, according to a study published online April 26 in the Journal of General Internal Medicine and a second study published May 14 in Antimicrobial Stewardship and

HealthDay 30 May at 03.42 PM

Some Healthy Teens Are Given Cannabidiol for Health Reasons

About 3 percent of healthy adolescents are given commercial cannabidiol (CBD) for health reasons, according to a study published online May 7 in Cannabis and Cannabinoid Research.Natasha E. Wade, Ph.D., from the University of California in San Diego, and colleagues described the characteristics of adolescents given health-related CBD (

HealthDay 29 May at 09.19 PM

In Utero Exposure to Antiseizure Meds Does Not Affect Child Creativity

There are no differences in creative thinking at age 4.5 years for children of women with epilepsy (WWE) and children of healthy women (HW), but fetal antiseizure medication (ASM) exposure-dependent effects are seen for executive function in children of WWE, according to a study published online May 29 in Neurology.Kimford J. Meador,

HealthDay 29 May at 09.17 PM

2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending

From 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to a research letter published online May 28 in JAMA Internal Medicine.Sukruth A. Shashikumar, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cro

HealthDay 29 May at 09.16 PM

Pharmacological Treatment of ADHD May Cut Some Forms of Criminality

Pharmacological treatment may reduce some types of criminality among adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD), according to a study published online in the April issue of the Journal of the American Academy of Child and Adolescent Psychiatry.Tarjei Widding-Havneraas, from Haukeland University H

HealthDay 29 May at 03.06 PM

Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation

Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in&nbsp;JAMA Network Open.Duy Do, Ph.D., from the Evernorth Research Institute in St. Louis, and colleagues estimated the prevalence

HealthDay 29 May at 03.05 PM

Chemo + Breast Cancer Combo Accelerates Functional Decline in Seniors

The combination of breast cancer and chemotherapy contributes to accelerated functional decline in older women with early-stage breast cancer, according to a study published online April 28 in the&nbsp;Journal of Cancer Survivorship.Mina S. Sedrak, M.D., from the University of California Los Angeles David Geffen School of Medicine, an

HealthDay 28 May at 10.06 PM

Infarct Size Does Not Affect Treatment Effect of Early Versus Late DOAC

For individuals with minor, moderate, or major stroke, the treatment effect of early versus late direct oral anticoagulant (DOAC) initiation does not differ, according to a study published online May 28 in JAMA Neurology.Martina B. Goeldlin, M.D., Ph.D., from the University of Bern in Switzerland, and colleagues examined whether infarct

HealthDay 28 May at 03.49 PM

Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease

Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease, according to a study presented at the annual European Renal Association Congress, held from May 23 to 26 in Stockholm.Helen M. Colhoun, M.D., from the University of Edinburgh in the United Kingdom,

HealthDay 28 May at 03.22 PM

Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older

For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published online May 28 in the Annals of Internal Medicine.Wanchun Xu, M.Phil., from the University of Hong Kong, and colleagues examined the benefits and risks of using statins for primary pre

HealthDay 28 May at 02.56 PM

ASCO: Conjugated Equine Estrogen May Increase Risk for Ovarian Cancer

Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.Rowan T. Chlebowski, M.D., Ph.D., from the Lundquist Institute in Torrance, Califor

HealthDay 24 May at 04.06 PM

Antihypertensives Linked to Eczematous Dermatitis in Seniors

Antihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and calcium channel blockers, according to a study published online May 22 in JAMA Dermatology.Morgan Ye, M.P.H., from the University of California in San Francisco, and colleagues examine

HealthDay 24 May at 04.01 PM

Donepezil Not Beneficial for Cognitive Impairment in Breast Cancer Survivors

A once-daily dose of donepezil does not improve cognitive function among breast cancer survivors exposed to chemotherapy one to five years earlier, according to a study published online May 6 in the Journal of Clinical Oncology.Stephen R. Rapp, Ph.D., from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, an

HealthDay 24 May at 11.21 AM

Louisiana Votes to Make Abortion Pills Controlled Substances

Louisiana has become the first state to pass a law that designates abortion pills as dangerous controlled substances.Once Gov. Jeff Landry signs the bill into law, as he is expected to do, possession of the drugs mifepristone and <a href="https://www.dr

HealthDay 23 May at 09.18 PM

ASCO: HPV Vaccination Positively Affecting More Than Just Cervical Cancer Risk

Human papillomavirus (HPV) vaccination is associated with reduced odds of several types of HPV-related cancers, not just cervical cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.Jefferson DeKloe, from Thomas Jefferson University in Philadelphia, and

HealthDay 23 May at 04.06 PM

Few Adults With Moderate, Severe Asthma Receive Recommended Inhaler Regimen

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended Single Maintenance and Reliever Therapy (SMART) inhaler regimen, according to a study presented at the American Thoracic Society 2024 International Conference, held from May 17 to 22 in San Diego.Zoe Zimmerman, from the Yale School of Medicine in N

HealthDay 23 May at 03.55 PM

Metformin Use Linked to Lower Odds of Myeloproliferative Neoplasms

Metformin use, including long-term use, is associated with significantly lower odds of myeloproliferative neoplasm (MPN) diagnosis, according to a study published online May 17 in Blood Advances.Daniel Tuyet Kristensen, M.D., from Aalborg University Hospital in Denmark, and colleagues conducted a population-based case-control study usi

HealthDay 23 May at 03.44 PM

Rates of Severe Multiple Drug Intolerance Syndrome Up in Fibromyalgia, IBS

Patients with fibromyalgia and irritable bowel syndrome (IBS) have increased rates of severe multiple drug intolerance syndrome (MDIS), according to a study published in the May issue of the Journal of Allergy and Clinical Immunology: In Practice.Alicia A. Alvarez, M.D., from Sarasota Memorial Hospital in Florida, and colleagues conduc

HealthDay 22 May at 09.01 PM

FDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus Erythematosus

The U.S. Food and Drug Administration has approved a 200-mg subcutaneous route of administration of Benlysta (belimumab) for patients 5 years of age and older with active systemic lupus erythematosus (SLE) who are receiving standard therapy.The B-lymphocyte stimulator-specific inhibiting monoclonal antibody was previously approved for children

HealthDay 22 May at 04.11 PM

GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults

For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research letter published online May 22 in the Journal of the American Medical Association.Joyce M. Lee, M.D., M.P.H., from the University of Michigan Medical School in Ann Arbor, and colleagues

HealthDay 22 May at 04.09 PM

Fish Oil Beneficial for Reducing Risk for Cardiovascular Disease Progression

The role of regular use of fish oil supplements varies for people with and without cardiovascular disease, according to a study published online May 21 in BMJ Medicine.Ge Chen, Dr.P.H., from Sun Yat-Sen University in Guangzhou, China, and colleagues conducted a prospective cohort study to examine the effects of fish oil supplements on

HealthDay 21 May at 03.14 PM

Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation

Dupilumab is associated with fewer exacerbations for patients with chronic obstructive pulmonary disease (COPD) with type 2 inflammation, according to a study published online May 20 in the New England Journal of Medicine to coincide with the American Thoracic Society 2024 International Conference, held from May 17 to 22 in San Diego.Su

HealthDay 21 May at 03.03 PM

Neurobehavioral Issues Increased in Children With Prenatal Fluoride Exposure

Prenatal fluoride exposure is associated with increased neurobehavioral problems, according to a study published online May 20 in JAMA Network Open.Ashley J. Malin, Ph.D., from the University of Florida in Gainesville, and colleagues examined associations of third-trimester maternal urinary fluoride (MUF) with child neurobehavior at age

HealthDay 20 May at 10.32 PM

Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes

Fezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of Endocrinology, hosted by the European Society of Endocrinology from May 11 to 14&nbsp;in Stockholm.Angelica Lindén Hirschberg, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleague

HealthDay 20 May at 03.55 PM

Bisoprolol Does Not Reduce Exacerbations in At-Risk COPD Patients

For patients with chronic obstructive pulmonary disease (COPD), bisoprolol does not reduce the number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both, according to a study published online May 19 in the Journal of the American Medical Association to coincide with the American Thoracic Society 2024 Internat

HealthDay 20 May at 03.47 PM

Guideline Developed for Glucocorticoid-Induced Adrenal Insufficiency

In a clinical guideline issued jointly by the European Society of Endocrinology and the Endocrine Society, recommendations are presented for the diagnosis and management of glucocorticoid-induced adrenal insufficiency. The guideline was published online May 8 simultaneously in the European Journal of Endocrinology and the Journal of Clinica

HealthDay 20 May at 03.41 PM

Acetaminophen Does Not Improve Survival in Adults With Sepsis

For adults with sepsis, intravenous acetaminophen is safe but does not significantly improve the number of days alive and free of organ support, according to a study published online May 19 in the Journal of the American Medical Association to coincide with the American Thoracic Society 2024 International Conference, held from May 17 to 22 in S

HealthDay 17 May at 04.30 PM

Andexanet Yields Better Control of Hematoma Expansion Than Usual Care

For patients who had taken factor Xa inhibitors within 15 hours before having an acute intracerebral hemorrhage, andexanet alfa, which reverses the effects of factor Xa inhibitors, results in better control of hematoma expansion than usual care, according to a study published in the May 16/23 issue of the New England Journal of Medicine.

HealthDay 17 May at 04.18 PM

Perioperative Nivolumab Tops Chemo for Survival in Resectable Lung Cancer

For patients with resectable non-small cell lung cancer (NSCLC), perioperative treatment with nivolumab results in significantly longer event-free survival, according to a study published in the May 16/23 issue of the New England Journal of Medicine.Tina Cascone, M.D., Ph.D., from the University of Texas MD Anderson Cancer Center in Hous

HealthDay 17 May at 04.00 PM

AAN Issues Guideline for Use of Antiseizure Meds in People of Childbearing Potential

In a practice guideline issued by the American Academy of Neurology, along with the American Epilepsy Society and the Society for Maternal-Fetal Medicine, recommendations are presented for the use of antiseizure medications (ASMs) among people with epilepsy of childbearing potential (PWECP). The guideline was published online May 15 in Neurology</em

HealthDay 17 May at 12.03 PM

FDA Approves New Drug for Deadly Lung Cancer

The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is only for pa

HealthDay 16 May at 09.18 PM

Semaglutide Reduces Need for Diuretics in Heart Failure

Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF), regardless of diuretic use, according to a study presented at the European Society of Cardiology Heart Failure 2024, held from May 11 to 14 in Lisbon, Portu

HealthDay 16 May at 04.06 PM

Aficamten Beneficial for Obstructive Hypertrophic Cardiomyopathy

Treatment with the oral selective cardiac myosin inhibitor aficamten results in significantly greater improvement in peak oxygen uptake compared with placebo among patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), according to a study published online May 13 in the New England Journal of Medicine to coincide with the Eu

HealthDay 16 May at 03.57 PM

Quality Improvement Initiative Boosts Early HPV Vaccine Rates

A multipronged primary care quality improvement initiative increases early human papillomavirus (HPV) vaccine initiation across racial/ethnic, sociodemographic, insurance, and geographic groups, according to a study presented at the annual meeting of the Pediatric Academic Societies, held from May 2 to 6 in Toronto.Caitlin Miller, from Nemours

HealthDay 16 May at 03.32 PM

Oldest Adults With Acute Myeloid Leukemia Benefit From Venetoclax

For older adults with acute myeloid leukemia (AML), venetoclax (VEN) combined with a hypomethylating agent (HMA) is safe and effective and can prolong survival, according to a study published online May 7 in Blood Neoplasia.Ellen Madarang, Pharm.D., from the University of Miami Sylvester Comprehensive Cancer Center, and colleagues cond

HealthDay 15 May at 03.45 PM

AACR Delivers Report on Disparities in Cancer Progress

In its biennial Cancer Disparities Progress Report published today, the American Association for Cancer Research presents the latest statistics on disparities in cancer progress experienced by ethnic-minority groups and other medically underserved populations in the United States.Robert A. Winn, M.D., from the Virginia Commonwealth Un

HealthDay 15 May at 03.23 PM

GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription

Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published online April 23 in&nbsp;Diabetes, Obesity, and Metabolism.Osvaldo P. Almeida, Ph.D., from University of Notre Dame in Fremantle, Australia, and colleagues assessed whet

HealthDay 14 May at 10.41 PM

Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist

One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to the results of a new KFF Health Tracking Poll, released May 10.Alex Montero, from KFF Health, and colleagues analyzed data collected April 23 to May 1, 2024, online and by te

HealthDay 14 May at 05.05 PM

About 8,000 Women Per Month Are Getting Abortion Pills Despite Their States' Bans

While some states have moved to severely curb women's access to abortion, including abortion pills, over 8,000 women living in those states are getting the pills by mail each month from states without such restrictions.That's according to new data from a <a href="https://societyfp.org/wp-content/uploads/2024/05/WeCount-report-6-May-2024-Dec-2023

HealthDay 14 May at 03.44 PM

Risk From Regular Cannabis Use Perceived as Low in Women With Disabilities

Women with disabilities have a low likelihood of perceiving a risk for harm from weekly cannabis use, according to a study recently published online in&nbsp;Cannabis and Cannabinoid Research.Panagiota Kitsantas, Ph.D., from Florida Atlantic University in Boca Raton, and colleagues examined the perceived risk for harm from weekly cannabi

HealthDay 13 May at 03.57 PM

Mail-Order Mifepristone Effective, Feasible for Medication Abortion

Mail-order pharmacy dispensing of mifepristone for medication abortion is effective, acceptable, and feasible, according to a study published online May 13 in JAMA Internal Medicine.Daniel Grossman, M.D., from the University of California, San Francisco, and colleagues estimated the effectiveness, acceptability, and feasibility of dispen